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ABSTRACT

Type 2 Diabetes (T2D) has been steadily rising in the United States. The
condition is characterized by elevated blood glucose levels and is preceded by insulin
resistance. Before the onset of T2D patients go through a state of pre-diabetes. To be
tested for pre-diabetes and diabetes, either a Fasting Plasma Glucose test or an Oral
Glucose Tolerance Test may be used. While an estimated 24 million Americans have
T2D, another 57 million Americans are estimated to be in a state of pre-diabetes. There
are many risk factors that may contribute to the development of T2D including obesity, a
high calorie diet, lack of physical activity, genetic factors and aging. The complications
associated with T2D may affect the kidney, nerves, eyes and feet. The prevalence of T2D
continues to increase in the US and around the world including the developing world.
Lifestyle interventions have been shown to be an effective way of treating and delaying
T2D. There is a need for an effective intervention to reduce the rising incidence of T2D.
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CHAPTER ONE
LITERATURE REVIEW

Introduction
Type 2 Diabetes (T2D) is one of the major causes of death in the United States.
The Centers for Disease Control and Prevention (CDC) has estimated that 8% of the US
population or about 24 million Americans are living with diabetes. Another 57 million
people are estimated to have pre-diabetes, and the total prevalence continues to increase
(1). By 2004 there were 1.3 million new cases of diabetes occurring annually in the
United States, and in 2007 the number of cases had risen to 1.6 million (2).
T2D is characterized by the body’s inability to adequately manage blood glucose levels.
T2D is usually preceded by insulin resistance which may indicate the initial stages of
elevated blood glucose, progressing to pre-diabetes and eventually to diabetes. Along
with insulin resistance, T2D may also be caused by genetic, environmental factors and
cell dysfunction (3). The two environmental factors that have been identified as
contributing the most to the development of T2D are a lack of physical activity and
unhealthy eating habits (4, 5, 6, 7, 8). The prevalence and the increasing rise in the
incidence of T2D, along with the factors potentially causing this disease, call for
innovative ways to diagnose, treat, and manage T2D.
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Diabetes versus Pre-diabetes
Definitions
Normal blood glucose levels are defined as fasting plasma glucose (FPG) <100
mg/dL. The hallmark of T2D is hyperglycemia which is defined as abnormally high
levels of blood glucose of >125 mg/dL using the FPG test. Before the onset of T2D, the
body goes through a period of elevated blood glucose termed “pre-diabetes”. Pre-diabetes
is a condition defined by impaired glucose tolerance (IGT) or impaired fasting glucose
(IFG) (7, 57). IGT is defined as a two-hour blood glucose levels (2h PG) of 140-199
mg/dL (7.8-11.0 mM/L) using the 75-g oral glucose tolerance test (OGTT), and IFG is
defined as glucose levels (FPG) of 100-125 mg/dL (5.6- 6.9 mM/L) after an 8 hour fast
(7, 9, 10).
The OGTT which measures IGT is a tool that is used to identify people who are at
a greater risk of developing diabetes (10). Schwartz reported in 2007 that the
development of diabetes and IGT could be predicted by impaired fasting glucose (11).
The utilization of both FPG and the OGTT has been instrumental in identifying
individuals who are at risk for diabetes. The FPG is quick and convenient while the
OGTT takes more time and is expensive, however, there remain questions about which
test is best used at various time in diagnosing T2D (10). Health professionals would like
to identify more easily people who are at risk of developing T2D so that they may be
provided useful education and interventions. One of the problems with diagnosis is that
most people do not know when to get tested or what the risk factors are for pre-diabetes
and diabetes. Individuals with IGT or IFG do not show any symptoms nor have scientists
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associated pre-diabetes with any known disabilities, conditions or specific biomarkers
(10). Perhaps the best early intervention would be to test people who have at least one
diabetes risk factor so that they will know their glucose level.
Many researchers have proposed that health professionals explore all avenues to
enable them to determine the specific blood glucose levels at which to start lifestyle
intervention for pre-diabetics (11, 12, 13). It would be ideal to keep the blood levels at
the normal range and avoid the development of hyperglycemia. The ability to identify
and treat people who are developing these early signs of diabetes could be a good starting
point in the quest to reverse the current upward trend of diabetes rates. To be successful
in combating the current surge of T2D cases, it is imperative to understand the
progression of pre-diabetes to diabetes (12).
Regulation of Blood Glucose Levels
Blood glucose levels are regulated by a negative feedback loop. Insulin and
glucagon are hormones produced by pancreatic cells. When the body is functioning
normally, insulin is released from the pancreatic β-cells into the blood in response to
increased levels of blood glucose. This generally happens after consuming food. The
glucose transporters help to usher glucose into the cells when blood glucose levels are
elevated and to the skeletal muscle for storage and fat cells for use, lowering blood
glucose levels. Glucose enters the liver by facilitated diffusion independent of insulin.
Sodium/glucose co-transporter (SGLT) use an symport Na+/glucose mechanism to move
glucose against a concentration gradient into the intestinal and kidney cells. Glucagon,
produced by the pancreatic alpha cells helps raise blood glucose levels. It stimulates
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glycogen catabolism in the liver when the blood glucose levels are low. Glucagon also
signals the liver to become active in gluconeogenesis and decrease its glycolytic activity.
It also signals the pancreas to stop insulin production when blood glucose levels increase.
This negative feedback loop helps maintain blood glucose homeostasis. Because they
lack the enzyme glucose 6 phosphatase, the muscles do not directly contribute to blood
glucose (although lactate produced in white muscle can be converted to glucose via the
Cori Cycle in the liver).
Etiology of Type 2 Diabetes
Insulin Resistance
Insulin resistance can be defined as a condition in which the body fails to properly
respond to insulin. This may be due to insulin deficiency, or the body’s inability to use
the available insulin. With insulin resistance, glucose concentration increases due to
glucose appearance exceeding glucose disappearance in the blood. Insulin concentration
will be increased simultaneously with the blood glucose concentration. When this
happens the cells will fail to respond to the available insulin and the pancreas will
produce more insulin because of the elevated blood glucose levels. However, sometimes
the pancreas is not able to produce adequate insulin to compensate for the increasing
insulin “resistance” and this may be a result of β-cells’ exhaustion (progressive decline in
β-cells’ function) (14). Insulin resistance may be a result of the reduction in the numbers
of insulin receptors, the affinity of the receptors or their diminishing function (15). This
may be a result of genetic predisposition or aging. Insulin resistance can develop
simultaneously with elevated blood glucose levels or it may occur independently. This
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negative feedback loop will not help if insulin receptors are decreased in number or
defective. Glucagon production may be inhibited by the high levels of insulin in the
blood. Blood glucose will continue to increase and may be at much higher levels than
normal. Over a period of time this will eventually lead to sustained elevated serum
glucose levels, termed hyperglycemia. Over time, the elevated levels of glucose in the
blood and the inability of the body to clear glucose fast enough from the blood, may
result in pre-diabetes and eventually T2D (16).
Obesity and Fat Distribution
There is an increase in the prevalence of diabetes, pre-diabetes, and obesity in the
adult population (17, 18). While previously thought to be adult onset diabetes, according
to the ADA, T2D is now diagnosed in >40% of all adolescence diabetes cases in certain
parts of the US (18, 19). This is of enough concern to call for a major policy change to
avoid a public health catastrophe (17, 20). The National Health and Nutrition
Examination Survey (NHANES) estimated the adult obesity rates at 33.8% (21). Several
studies have reported that 85-90% of people who have T2D are usually overweight or
obese (22, 23, 24, 25, 26). Individuals whose Body Mass Index (BMI) range from 2529.9 are said to be overweight, while those with a BMI of over 30 are considered to be
obese. BMI is an indicator of body fat based on an individual’s height and weight.
Obesity will often precede insulin resistance and eventually T2D. However,
overweight or obese people who do not have high amounts of intra-abdominal fat may be
able to remain in the state of insulin resistance with less chance of developing diabetes
(27). As a result, obesity increases the risk of developing T2D, but is not a guaranteed
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risk factor for T2D. Fat distribution plays a role in determining the level of risk that may
be associated with the development of diabetes. Fat may be distributed viscerally or
peripherally in the body. Peripheral subcutaneous fat is the fat that is deposited under the
skin and is mostly well distributed over the body, mostly in the hips, upper arms and
thighs. Visceral fat is stored in the abdomen and it is thought to have a higher metabolic
activity level. When visceral fat is accumulated in organs such as the liver and muscle, it
is likely to impair the function of organs and this may contribute to insulin resistance (28,
29). This may also be caused by increased lipolysis, along with impaired glucose uptake
which will lead to elevated free fatty acids. This is also likely to eventually lead to insulin
resistance. Fatty acids will bind to the cell membranes of non-adipose cells and this will
result in the impaired function of the tissue. An example of this would be skeletal muscle
cells which will be less efficient if the free fatty acids bind to their membrane and as a
result reduce their effectiveness at glucose uptake (30, 31).
Nuclear factor κB (NF-κB) is a nuclear transcription factor that regulates DNA
transcription (32). It is found in the cytoplasm bound by inhibitor protein. NF-κB
activates gene expression for inflammatory compounds, regulation of cell proliferation
and apoptosis in response to stimuli such as stress, free radicals, cytokines, lymphokines
and growth factors (33) and may contribute to incidences of autoimmune disease. Studies
have reported that high levels of fat and fatty acids can lead to the activation Jun Nterminal kinase (JNK), inhibitor of NF-κB kinase (IKK), and novel isoforms of protein
kinase C in insulin sensitive cells (30, 34, 35) (Fig.1). This could happen in the
adipocytes, liver and skeletal muscle cells. Once activated, the kinases can lead to
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“inflammation and cell adhesion” (30, 36, 37). Individuals whose fat mass is mostly
distributed as peripheral subcutaneous fat may have less risk for development of
diabetes; while fat that is mostly distributed in the abdomen will result in an increased
risk for diabetes. This is because excessive abdominal fat contributes to the development
of insulin resistance by releasing high amount of free fatty acids into the blood. High
levels of lipid accumulated in non adipose tissue is associated with insulin resistance
(80). This conclusion is consistent with the fact that about 90-95% of all people with
diabetes have T2D and about 90% of those who have T2D are either overweight or obese
(24, 25).
A number of studies have shown that increased subcutaneous abdominal fat or
increased visceral fat may underlie central adiposity, particularly if the two conditions are
coexisting (6, 22, 23). However, using a CT scan, Bray and colleagues found that
subcutaneous fat measured by CT scan did not predict diabetes, and that waist
circumference was a much better predictor of diabetes risk (22). In an earlier study of
participants who were in a fat and weight reduction targeted exercise regimen, Carr and
colleagues found that people who decreased their weight and body fat had better insulin
sensitivity. They also found that the decrease in “weight and intra-abdominal fat, but not
percent body fat or abdominal subcutaneous fat, were associated with a 24-month
positive improvement in β-cell function” (6). The findings from Bray’s study seem to
suggest that being overweight or obese does not necessarily lead to the development of
diabetes. The Carr study indicates that intra-abdominal fat could be a more reliable target
for fat reduction. This information should be borne in mind for understanding the
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complexities of the disease and when designing interventions that could restore the
quality of life for many people who have T2D.

Environmental Factors
Diet
A diet high in calories and saturated fat will likely result in the development of
obesity, unless the calorie consumption is countered with adequate caloric expenditure. A
balanced diet is one of the more effective approaches to diabetes prevention and
treatment. The 2005 Dietary Guidelines for Americans recommends that a person on a
2000 kcal diet plan should consume a diet composed of 45-65% kcal from carbohydrates,
20-35% from fat (< 10% saturated fat), and 10-35% of protein (38). The USDA
MyPyramid recommends that this person should consume at least 2 cups of fruits, 2.5
cups of vegetables, 6 oz of grains, 5.5 oz of meats and legumes, 3 cups of milk, and 6
teaspoons of oil each day (39). However, when people are given a choice they seem to
select foods which are high in saturated fat and low in vegetables, fruits, and whole
grains. It is possible to consume only foods that are considered to be healthy, and still
become overweight or obese or even develop diabetes. As a result, while it is important
to consume foods that are high in fiber and whole grain, the total amount of calories
consumed also needs to be considered (40). In a Finnish study (n = 4,344) of dietary
patterns, participants aged 40-69 consumed a diet high in vegetables and fruits or one
high in butter, potatoes, and whole milk (79). Researchers found those participants whose
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dietary patterns included high amount of fruits (185 ± 143 g/day) and vegetables (180 ±
85.4 g/day) had a lower risk of developing diabetes. In the study of Schulze et al. 35,
340 participants aged 30–55 yrs whose self- reported dietary patterns were high in refined
grains, sweetened drinks and processed meat had a higher risk of developing diabetes
associated inflammation (41). Dietary patterns with high vegetable and fruit consumption
can be clearly associated with a reduction in risk of developing diabetes.
For people living with diabetes, keeping blood glucose levels as close to normal
as possible is the major goal. This can be hard to achieve for many patients, and since
diabetes could be caused by different factors in different people, one approach to lower
blood glucose may not achieve desired results for all diabetes patients (42). An
individualized approach is therefore vital for successful diabetes treatment.
Notwithstanding effects of reducing diabetes due to dietary changes, treating diabetes
with diet is difficult because changing what people eat for the rest of their lives or
changing the consumption of foods that define their culture is a daunting task (43, 44).
People may be able to reduce their weight through a weight loss regimen which includes
lifestyle changes of caloric restriction and physical activity. However, it has been
reported that most people who lose their weight regain it one year later (40). This may
help explain the ever-increasing rates of obesity and excess weight which in turn have a
negative impact on the diabetes rates.
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Physical Activity
Along with nutrition, physical activity is a major component of maintaining a
healthy lifestyle. The CDC defines physical activity as “any bodily movement produced
by the contraction of skeletal muscle that increases energy expenditure above a basal
level” (45). Drawing from this definition, it would be wise to state the difference between
physical activity and exercise because the two terms are sometimes used interchangeably.
Exercise is a kind of physical activity which is usually designed and structured to
increase physical fitness (45, 46). There are three components that can be used to assess
the level of physical activity or of exercise and these are frequency, intensity and
duration.
The frequency of the exercise or physical activity is an important aspect of the
exercise program. It is important that an exercise reach the objective for which it was
initially intended, and an exercise program should be performed for the duration of the
time prescribed. The CDC and the American College of Sports Medicine (ACSM)
recommend that people should participate in 30 min of moderate physical activity 3-5
times weekly (45, 46). The intensity of an exercise program can be measured using the
metabolic equivalent (MET), where 1 MET is the rate of energy expenditure while sitting
at rest for an hour (47). With this in mind the intensity of an exercise program can be
defined as being light, moderate or vigorous activity. On a scale of 0-10, low intensity
requires an energy expenditure of < 3 MET, while 3-5.9 is moderate intensity and 6-8 is
classified as intense (45).
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A number of studies have shown that physical activity along with diet can
prevent, delay and reduce the risk of developing diabetes (7, 48, 49, 50, 51, 52, 53, 54,
55). For diabetes management and risk reduction, regulation of blood glucose levels
should be borne in mind in order to achieve the desired blood glucose results. When
performed at the above mentioned recommended levels of 30 min of moderate physical
activity for 3 to 5 x/week, physical activity may produce many benefits including
improvement of carbohydrate metabolism, insulin sensitivity, reducing cardiovascular
risk, weight loss and weight maintenance, among others (45).
Genetic Factors
There is some evidence that fasting plasma glucose is increased when the β-cell
function is decreased and that this may explain the subsequent increase in IFG for T2D
(56). In individuals who have T2D, elevated blood glucose levels will continue to
increase, without proper management and treatment (55). Obesity is a major risk factor
for diabetes; however, if β-cell dysfunction occurs in conjunction with insulin resistance
there will be an increased risk for an early onset of diabetes (20). If the body has
declining β-cell function caused by genetic predisposition or other factors such as
infection that can ultimately lead to low insulin levels, a cascade of events will likely
occur which will increase the risk of development of T2D (14, 20). It has been reported
that even after weight loss maintenance, people who are at a high risk of developing
diabetes are still likely to experience continually declining β-cell function (6). Meyer et
al. found that β-cell function, as measured by basal insulin release was impaired in
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individuals who had impaired fasting glucose, but not in individuals with impaired
glucose tolerance (56).
If insulin resistance occurs as the result of the body’s inability to use insulin and
the β-cells are functioning, then the β-cells may become exhausted due to increased
insulin demand. This leads to hyperglycemia. After a number of years of having insulin
resistance, the body will eventually progress to pre-diabetes and eventually diabetes (58)
Stress
Glucocorticoids increase in response to either physiological or psychological
stress, but elevated and chronic levels of glucocorticoids will promote the development of
obesity, particularly visceral obesity, because fat cells in the abdomen are more sensitive
to cortisol (57). Glucocorticoids may promote insulin resistance by reducing glucose
production and also reducing glucose uptake in order to preserve the available energy
(58).
Family History
Lyssenko and colleagues reported that a family history of T2D was a major risk
factor for the development of diabetes. They also indicated that the risk of diabetes was
not reduced for the second relative of the diabetes patient (5). This is particularly
disturbing given the report by Cowie and colleagues indicating that about 35.3% of the
adults in the US had diabetes or pre-diabetes (17).
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Gender Differences
There may be a gender bias to the development and prevalence of diabetes;
however, different studies have shown variable results (59, 60). Women who gain excess
weight during pregnancy may increase their chances of developing gestational diabetes.
Women who have gestational diabetes have a 40% to 60% chance of developing T2D in
5 to 10 years (61, 81). Gender differences may be influenced by culture. A study of
Iranian subjects found no significant difference in the prevalence of diabetes on the basis
of gender (62). However, that country’s national survey found a significant difference in
the age-related prevalence (P = 0.003) of diabetes for women and men (8.3% vs. 7.1%)
(17). The 2007 US Diabetes National Fact Sheet indicated 11.2% of men ≥20 years had
diabetes, while 10.2% of women in this age group had the disease (61). In the US, the
increased prevalence of diabetes in men (and women) may be influenced by their higher
prevalence of obesity indicated by a BMI ≥30 (63).
Age
Age is a major risk factor for diabetes. The risk of developing diabetes increases
at age 45, while the majority of people who have T2D are ≥ 55 yrs. (64). This risk usually
peaks at ages 70-79 in most people (65). There are different reasons why middle aged
people are more susceptible to developing diabetes. The pancreatic beta cells’ production
is decreased with age, and middle aged people often lose lean muscle tissue and increase
adipose tissue. These factors may contribute to insulin resistance and eventually the
development of diabetes. Ideally, delaying the onset of T2D would reduce complications
and conditions related to diabetes (5, 7, 8). Additionally, conditions such as retinopathy,
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high blood pressure and high cholesterol can be delayed or prevented by diabetes
prevention interventions (44, 54, 66).
Educational Attainment
The prevalence of diabetes is highest in those who have <12 years of formal
education (67). The benefits of modern research, intervention and treatment have
substantially favored those with <12 years of education (68). This may be due to the fact
that those with higher educational achievement are more likely to have access to and to
embrace new technologies. The Danish national dietary survey found that men who had
<12 years of education consumed less fruit (108±7.8 g/10MJ); and vegetables
(84±8.4g/10MJ) in comparison with those who had more than 12 years of education, (
fruits, (154±11.5g/10MJ); vegetables 126±9.5g/10MJ, P<0.001). (83). A Scottish survey
found a higher education was associated with a higher health eating score for both men
(22.6 vs 20.0) and women (25.3 vs 22.2) (84). It was suggested that lack of understanding
and financial resources may also contribute to these differences. In a review of diabetes
trends from 1989 – 2005, the prevalence of diabetes among middle-aged participants was
higher (15.94%) in those with less than a high school education and lower (12.81%) in
those with more high school (68). This pattern clearly suggests that education was a
significant factor in diabetes prevalence and possibly for general health. In the same
study, mortality rates were compared over 16 years. For middle-aged individuals, the
mortality rate increased (75%) for those with lower levels of education while the rate
decreased (7%) to (10.37) for those who had at least a college education or more than 12
years of schooling (68). Educational attainment was clearly an important factor in
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diabetes care and prevention, and those who had more education were more likely to reap
the benefits of any available care, intervention and treatment.
Increasing Prevalence
Type 2 diabetes is growing at a very fast rate in the U.S. and it continues to have a
negative economic and public health impact on society (69). The disease has been shown
also to be an emerging condition of major concern for American children (19). The
current increasing rate for both adults and adolescents indicates that diabetes will
continue to be a major cause of concern for the American public in the future (20).
Banjamin et al. (70) reported that in 2000, about 25% of the overweight adults
who were between the ages of 44 and 75 had pre-diabetes, i.e., about 12 million adult
Americans. By 2006, about 35.3% of the adults in the US had diabetes or pre-diabetes, a
percentage that was equivalent to about 73.3 million Americans (17, 70). The CDC
National Diabetes Fact Sheet report of 2007 stated that about 23% of the adult population
over the age of 60 in the U.S. had diabetes (6). The CDC reported the number to be 24
million by the year 2008. What was also disturbing about this report was that about than
25% of those who had the disease did not even know about it (1).
The Southern States
While the adult incidence rates of diabetes have increased throughout the U.S.,
the rate of increase has been much higher in the Southern states. In South Carolina the
rate of increase for adults was 113% in 2008 when comparing the diabetes rates from
2005-2007 with those from 1995-1997 (CDC, 2008). In 2010 the prevalence of diabetes
in South Carolina was 10% compared to 4.9% in 1997 (82). The CDC report showed that
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of all the states surveyed, South Carolina was second only to West Virginia in the
prevalence of diabetes (1).
Worldwide Prevalence
The increasing diabetes prevalence rate is not limited to the United States: Rates
are increasing in all populations around the world (54). Diabetes affects the developed
and developing nations (71, 72, 54). Despite years of concern about the problem, not
enough has been done to avert the continuing trend. In 1997, Pan and colleagues warned
about the risk of diabetes and that diabetes will be a public burden. They also expressed
concern that diabetes would lead to vascular complications which may lead to morbidity
and premature death (72). It is thought that “population growth, aging, urbanization, and
increasing prevalence of obesity and physical inactivity” are the main contributing factors
to the increasing diabetes rates (73). Motala and colleagues reported that the peak age for
diabetes prevalence in South Africa was 55-64 years (71). This age-related prevalence
was also the case in China where diabetes increased with age and personal annual income
and was about three times higher than 10 years ago (72, 73). In many countries
urbanization, obesity and aging may be the major factors behind the increasing diabetes
prevalence.
Diabetes Complications
Many studies have documented a strong correlation between diabetes, prediabetes and heart disease and low life expectancy (6, 70, 74, 75). Effective interventions
could help lessen the risk for all of these conditions (54). Benjamin and colleagues found
that among individuals who had pre-diabetes, the incidence of CVD risk factors was
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high: dyslipidemia (94.9%), hypertension (56.5%), smoking (16.6%), and
microalbuminuria (13.9%) (70). Diabetes takes a toll on the body because it usually
occurs with many other risk factors such as hypertension, hypertriglyceridemia, low
HDL-cholesterol, and high concentration of small dense LDL (75).
The National Institute of Diabetes and Digestive and Kidney Diseases reported
that diabetes complications affect many organs but most of the damage typically occurs
in the kidney, nerves, eyes and feet (76). Diabetic nephropathy occurs when high blood
glucose causes kidney damage. When the kidneys are damaged their ability to filter
impurities from the body could be compromised and this may lead to kidney failure (76).
In diabetes, when high blood glucose causes damage to the nerves it is termed diabetic
neuropathy. This occurs when the linings of the nerves and blood vessels are damaged
and may cause diabetic patients to lose feeling in their feet. The glucose transporter
(glucose permease) of the red blood cells is not sensitive to insulin and operates merely
based on blood glucose levels. As a result, when the blood glucose is elevated glucose
movement into the red blood cells will increase. So the result is increased A1c and all the
attendant problems which are associated with the statements below. Very high A1c
reduces efficiency of the Bohr Effect and reduces oxygenation of the tissues. The blood
oxygen is reduced due to the defective hemoglobin and its inability to transport oxygen
effectively. Elevated A1c also reduces nitric oxide transport which leads to failure of
vasodilation and subsequent increased blood pressure. Damage to the blood vessels (and
defective hemoglobin) may reduce oxygen to the feet and reduce transport of nitric oxide
which will adversely affect vasodilation and lead to foot damage and even amputation.

17

Diabetic retinopathy occurs when the blood vessels of the retina in the eyes are damaged.
This may lead to blurry vision or blindness. Diabetes also increases the risk of having a
heart attack and stroke and most people with diabetes die from heart attack (69, 70).
Diabetes and Pre-diabetes Intervention and Prevention
There is great interest in the medical community regarding how to detect diabetes
and pre-diabetes in the early stages (77). This is particularly important as the
development and progression of pre-diabetes to diabetes occurs over many years (58).
Because pre-diabetes is asymptomatic, patients are not alerted to the problem and as a
result, pre-diabetes may go undetected until diabetes actually develops (10, 54). Another
problem is that the limited available methods of treatment, such as drug treatment, remain
inadequate and do not provide a cure, which makes prevention highly desirable (49).
Preventative intervention seems to be the most viable and reasonable option, and with
more than 73.3 million Americans who have diabetes or pre-diabetes the need for
intervention is quite strong (17). A successful intensive intervention for both diabetes and
pre-diabetes will be challenging and will not produce the desired results overnight,
because obesity (as one of the main contributing factors) and diabetes develop over many
years (58). It is likely that successful interventions require lifelong lifestyle change with
the additional involvement of local communities and organizations (7). It is inevitable
that the cost of this kind of intervention will be large and it would be wise to have reliable
risk and cost assessments prior to embarking on such a large endeavor (75). The cost of
large intervention studies may be substantially high in monetary and emotional terms;
however, the expected reduced morbidity and mortality rates linked to the remediation of
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T2D justify this kind of investment (20). Investing in the community’s health in the form
of accessible intervention and wellness programs will be helpful and rewarding for the
public and may reduce the public health burden of diabetes (53).
Many studies have shown that diabetes can be prevented or delayed by lifestyle
intervention in people who are in a pre-diabetic state, and that reduction in weight and an
increase in physical activity can decrease the risk of developing diabetes for people who
have pre-diabetes (8, 53, 54, 56). Some of the more notable diabetes intervention studies
are the Chinese Da Qing IGT and Diabetes Study, Diabetes Prevention Program, as well
as the Finnish Diabetes Prevention Study. In the above mentioned studies, researchers
found that over a period of 3 years or more, there was a reduction in the development of
diabetes by 42–58% as a result of their lifestyle intervention programs (4, 51, 55, 75). In
the Finnish study, researchers found that weight loss and increased physical fitness were
equally correlated to improved glucose tolerance which decreased by –2±12 mg/dL when
compared to an increase of +0.2±0.8 mg/dL in the control group (P<0.001) (53).
Individuals who reduced their weight and increased their oxygen uptake attained the best
improvement. This indicated that weight reduction along with physical activity were the
best interventions when applied together. Additionally Lindstrom and colleagues reported
that participants had an A1c metabolic improvement of -0.2 ± 0.6 in the treatment group
compared to an increased A1c in the control group ( 0.06+/ P= 0.002), and that if the
dietary counseling and resistance training and increased physical activity lifestyle
changes used in the intervention were continued diabetes could be delayed by several
years (54). In 2005, Carr and colleagues reported that lifestyle modifications consisting of
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the American Heart Association (AHA) Step 2 diet and endurance exercise for 24 months
in Japanese Americans with IGT improved insulin sensitivity, decreased percentage body
fat, reduced visceral and subcutaneous abdominal fat and increased weight loss (6).
Interventions may need to be designed differently for different populations and
locations, taking into consideration cultural and social aspects of each community (53).
When designing an intervention it would be more cost effective to focus on the
communities that are more severely affected by obesity and diabetes, thus providing a
greater initial impact on reducing the prevalence of diabetes in the future (76). It appears
reasonable to introduce lifestyle interventions to people who are at a higher risk of
developing diabetes before a diagnosis of pre-diabetes, especially in individuals who are
obese. As individuals age, β-cell function decreases and they are more inclined to gain
weight. This makes long-term lifestyle intervention more difficult (6). It would be a
challenge for public health professionals to single out obese people to participate in
interventions because not all obese people develop diabetes (24, 25).
Those who have pre-diabetes should be given priority for lifestyle interventions as
they are at a much higher risk of developing diabetes (57). Individuals with IGT may
reduce T2D risk by implementing lifestyle modifications resulting in improved insulin
sensitivity, improved β-cell function or both (6). It has been reported that increasing
regular physical activity and preventing weight gain are essential in order to slow down
the transition toward the high visceral adipose fat content and high insulin resistance state
shown to promote the highest metabolic risk for diabetes (78).
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Conclusions
Diabetes prevalence has continued to increase along with the obesity prevalence.
There is a need for an effective and feasible solution to curb this prevalence. Public
health professionals have implemented many strategies to address the obesity epidemic
including diabetes education and promotion of physical activity and a healthy diet.
Diabetes interventions involving exercise and diet are more likely the better approach to
treating and preventing diabetes. However, while most studies including the large-scale
Da Qing IGT and Diabetes Study, the Diabetes Prevention Program, and the Finnish
Diabetes Prevention and the work of Carr et.al showed insulin sensitivity improved with
diet and exercise; there have been some conflicting data, with a lesser number of studies
showing minimal improvement in glucose tolerance and β-cell function (3, 6, 57). Given
the evidence, it is reasonable to conclude that since current medications have shown little
or no success in combating the onset and prevalence of diabetes, it would be better to use
preventative measures. Individuals who have a diagnosis of pre-diabetes and those who
have diabetes risk factors should be informed of the lifestyle changes that can reduce the
risk of developing diabetes.

21

References

1. Centers for Disease Control and Prevention. Number of People with Diabetes
Increases to 24 Million. Estimates of Diagnosed Diabetes Now Available
for all U.S. Counties. Available at:
http://www.cdc.gov/media/pressrel/2008/r080624.htm
Accessed March 20, 2009.
2. American Diabetes Association. Diabetes statistics. 2007. Available at:
http://www.diabetes.org/diabetes-basics/diabetes statistics/
Accessed March 25, 2009.
3. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth Type 2 Diabetes
Insulin resistance,ß-cell failure, or both? Diabetes Care. 2005;28:638-644.
4. Jonker JT, De Laet C, Franco OH, Peeters A, Mackenbach J, Nusselder WJ.
Physical activity and life expectancy with and without diabetes: life table
analysis of the Framingham Heart Study. Diabetes Care. 2006;29:38-43.
5. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B,
Forsen B, Homstrom N, Saloranta C, Taskinen M, Leif G, Tuomi T. For
the Botnia Study Group. Diabetes. 2005;54:166–174.
6. Carr DB, Utzschneider KM, Boyko EJ, Asberry PJ, Hull RL, Kodama K,
Callahan HS, Matthys CC, Leonetti DL, Schwartz RS, Kahn SE, Fujimoto
WY: A reduced-fat diet and aerobic exercise in Japanese Americans with
impaired glucose tolerance decreases intra-abdominal fat and improves
insulin sensitivity but not β-cell function. Diabetes. 2005;54:340–347.
7.

Ackermann RT, Finch EA, Brazening E, Zhou H, Marrero DG. Translating the
Diabetes Prevention Program into the Community: The DEPLOY Pilot
Study. American Journal of Preventaive Medicine. 2008;35(4):357–363.

8. Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma
Y, Vittinghoff E, Kanaya AM. Lifestyle intervention is associated with
lower prevalence of urinary incontinence: the Diabetes Prevention
Program. Diabetes Care. 2006;29:385–90.
9. Rao SS, Disraeli P, McGregor T. Impaired glucose tolerance and impaired
fasting glucose. American Family Physician. 2004;69:1961-8.

22

10. Stern PM, Williams K, Haffner SM. Identification of Persons at High Risk for
Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
Annals of Internal Medicine. 2002;136:575-581.
11. Schwarz PE, Bornstein SR. Pre-diabetes and metabolic syndrome in Germans.
Hormone and Metabolism Research. 2006;38:359.
12. Perreault L, Bergman BC, Playdon MC, Man CD, Cobelli C, Eckel RH.
Impaired fasting glucose with or without impaired glucose tolerance:
progressive or parallel states of pre-diabetes? American Journal of
Physiology, Endocrinology and Metabolism. 2008;95:428-435.
13. Schwarz PEH, Bornstein SR, Hanefeld M. Elevated fasting glucose levels
predicts IGT and diabetes also in middle-age subjects. Diabetes Research
and Clinical Practice. 2007;77:48–150.
14. Rhee SY, Chon S, Oh S, Kim SW, Kim J, Kim YS, Woo J. Insulin secretion
and insulin resistance in newly diagnosed, drug naive pre-diabetes and
type 2 diabetes patients with/without metabolic syndrome. Diabetes
Research and Clinical Practice. 2007;76:397–403.
15. Stefan N, Thamer C, Staiger H, Machicao F, Machann J, Schick F, Venter C,
Niess A, Laakso M, Fritsche A, Haring HU. Genetic variations in PPARD
and PPARGC1A determine mitochondrial function and change in aerobic
physical fitness and insulin sensitivity during lifestyle intervention.
Journal of Clinical Endocrinology Metabolism. 2007;92:1827–1833.
16. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history
of progression from normal glucose tolerance to type 2 diabetes in the
Baltimore Longitudinal Study of Aging. Diabetes. 2003;52:1475–1484.
17. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau
MM, Saydah SH,Williams DE, Geiss LS, Gregg EW. Prevalence of
diabetes and impaired fasting glucose in adults in the U.S. population:
National Health and Nutrition Examination Survey 1999–2002. Diabetes
Care. 2006;29:1263–1268.
18. Grinstein G, Muzumdar R, Aponte L, Vuguin P, Saenger P, DiMartino-Nardi J.
Presentation and 5 year follow-up of type 2 diabetes mellitus in AfricanAmerican and Caribbean- Hispanic adolescents. Hormone Research in
Pediatrics. 2003;60(3):121–126.
19. American Diabetes Association. Type 2 Diabetes in Children and Adolescents.
Diabetes Care. 2000;23(3):381–390.

23

20. Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D’Alessio DA ß-Cell Function,
Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and
Nondiabetic Adolescents and Young Adults. Journal of Clinical.
Endocrinology Metabolism. 2006;91:185–191.
21. Flegal KM, Carroll DM, Ogden CL, Curtin LR. Prevalence and Trends in
Obesity Among US Adults, 1999-2008. Journal of American Medical
Association. 2010;303:235–241.
22. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson
RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX. For the
Diabetes Prevention Program Research Group Relation of central
adiposity and body mass index to the development of diabetes in the
Diabetes Prevention Program. American. Journal of. Clinical Nutrition.
2008;87:1212–1218.
23. Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner
S, Hanson R, Hill JO, Hubbard V, Stamm E, Pi-Sunyer FX. For the
Diabetes Prevention Program Research Group Body Size and Shape
Changes and the Risk of Diabetes in the Diabetes Prevention Program.
Diabetes. 2007;56:1680–1685.
24. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and
impaired glucose tolerance and plasma glucose levels in U.S. population
aged 20–74. Diabetes. 1987;36:523–534.
25. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes
epidemic. Nature. 2001;414(6865):782–7.
26. Centers for Disease Control and Prevention. Prevalence of Overweight and
Obesity Among Adults with Diagnosed Diabetes --- United States, 1988-1994 and 1999—2002. Available at:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a2.htm
Accessed April 20, 2010.
27. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks
JS. Prevalence of obesity, diabetes, and obesity-related health risk factors.
Journal of American Medical Association. 2001;289:76–79.
28. Unger RH, Zhou Y-T, Orci L. Proceedings National Academy of Sciences. U.S.A
1999; 96:2327-2337.

24

29. Houmard JA. Intramuscular lipid oxidation and obesity. The American Journal
of Physiology -Regulatory, Integrative and Comparative Physiology.
2008;294:R1111–R1116.
30. Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in
nonalcoholic hepatitis. Hepatology. 2008;48(2):670-678.
31. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki–Jarvinen H.
Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose
Tissue Insulin Resistance in Type 2 Diabetes. Gastroenterology. 2008;
135(1) 122-130.
32. Ignatowicz E, Baer-Dubowska W. Resveratrol, a natural chemopreven-tive
agent against degenerative diseases. Polish journal of pharmacology.
2001;53(6):557-69.
33. D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-κB):
an emerging theme in anti-inflammatory therapies. Molecular
Interventions. 2002;2:22-35.
34. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. Journal
of Clinical Investigation. 2006;116:1793-1801.
35. Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2-terminal
kinase pathways in inflammation and origin of obesity and diabetes.
Diabetes. 2005;54(Suppl 2):S73-S78.
36. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation,
mitochondrial function and fat oxidation results in ectopic fat storage,
insulin resistance and type II diabetes mellitus. International Journal of
Obesity. 2004;28:S12–S21.
37. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki–Järvinen H.
Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose
Tissue Insulin Resistance in Type 2 Diabetes. Gastroenterology. 2008;
135(1)122-130.
38. U.S. Department of Agriculture and U.S. Department of Health and Human
Services. Dietary Guidelines for Americans. 2005.
39. United States Department of Agriculture. My Pyramid Available at:
http://www.mypyramid.gov/. Accessed January 22, 2010.

25

40. Foreyt JP. Evidence for success of behavior modification in weight loss
control. Annals of Internal Medicine. 1993;119:698-701.
41. Schulze M, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C,
Heidemann C, Colditz GA, Hu FB. Dietary pattern, Inflammation, and
incidence of type 2 diabetes in women. American Journal of Clinical
Nutrition. 2005;82:675–684.
42. American Diabetes Association: Standards of medical care for patients with
diabetes mellitus. Diabetes Care. 1998;(Suppl.1):S23-S31.
43. Bantle JP: Thoughts on the dietary treatment of diabetes mellitus. Diabetes
Care. 1992;15:1821-1823.
44. American Diabetes association: American Diabetes Association Guide to
Medical Nutrition Therapy. Alexandria, VA. American Diabetes
Association, 1999.
45. Centers for Disease Control and Prevention (CDC). Division of Nutrition,
Physical Activity and Obesity, National Center for Chronic Disease
Prevention and Health Promotion, 2008.
46. American College of Sports Medicine. Guidelines for Exercise Testing and
Prescription. 6th ed. Baltimore, Md: Lippincott Williams & Wilkins,
2000.
47. U.S. Department of Health and Human Services, Public Health Service,
Centers for Disease Control and Prevention, National Center for Chronic
Disease Prevention and Health Promotion, Division of Nutrition and
Physical Activity. Promoting physical activity: a guide for community
action. Champaign, IL: Human Kinetics, 1999.
48. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Östenson CG.
Psychological distress and risk of pre-diabetes and Type 2 diabetes in a
prospective study of Swedish middle-aged men and women. Diabetic
Medicine. 2008;25:834–842.
49. Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P,
KeinänenKiukaanniemi S, Laakso M, Lauhkonen M, Lehto P,
Lehtonen P, Louheranta A, Mannelin M, Martikkala V, Rastas M,
Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Eriksson KF,
Lindgiirde E. Prevention of Type 2 (non-insulin-dependent) diabetes
mellitus by diet and physical exercise: The 6-year Malmo feasibility study.
Diabetologia. 1991;34:891-898.

26

50. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker
EA, Nathan DM. The Diabetes Prevention Program Research Group:
Reduction in the incidence of type 2 diabetes with lifestyle intervention or
metformin. New England Journal of Medicine. 2002;346:393–403.
51. Pan X, Yang W, Li G, Liu J. The National Diabetes Prevention and Control
Cooperative Group: Prevalence of diabetes and its risk factors in China,
1994. Diabetes Care. 1997;20:1664-9.
52. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamaainen H, IlanneParikka P, Keina¨nen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas
M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by
changes in lifestyle among subjects with impaired glucose tolerance. New
England Journal of Medicine. 2001;344:1343–1350.
53. Tuomilehto J. On behalf of the Finnish Diabetes Prevention. Study Group
Prevention of Type II diabetes in subjects with impaired glucose tolerance:
the Diabetes Prevention Study (DPS) in Finland. Diabetologia 1999;
42:793-801.
54. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J,
Uusitupa M, Tuomilehto J. The Finnish Diabetes Prevention Study (DPS):
lifestyle intervention and 3- year results on diet and physical activity.
Diabetes Care. 2003; 26(12):3230-6.
55. Mason CC, Hanson RL, Knowler, WC. Progression to Type 2 Diabetes
Characterized by Moderate Then Rapid Glucose Increases. Diabetes.
2007;568:2054-2061.
56. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin
secretory dysfunction and insulin resistance in the pathogenesis of type 2
diabetes mellitus. Journal of Clinical Investigation. 1999;104:787–794.
57. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in
man: impared suppression of glucose production and stimulation of
glucose utilization due to a postreceptor detect of insulin action. Journal of
Clinical Endocrinology and Metabolism. 1982;54:131-138.
58. Macfarlane DP, Forbes S, Walker BR. Glucocorticoids and fatty acid
metabolism in humans: fuelling fat redistribution in the metabolic
syndrome. Journal of Endocrinology. 2008;197:189–204.

27

59. Cowie CC, Eberhardt MS. Sociodemographic characteristics of persons with
diabetes. In National Diabetes Data Group. Diabetes in America, 2nd ed.
Washington, DC: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, 1995;85-116.
60. Kenny SJ, Aubert RE, Geiss MA. Prevalence and incidence of non-insulindependent diabetes. In: National Diabetes Data Group. Diabetes in
America, 2nd ed. Washington, DC: National Institutes of Health, National
Institute of Diabetes and Digestive and Kidney. Diseases, 1995;47-67.
61. Centers for Disease Control and Prevention, National Diabetes Fact Sheet:
General Information and National Estimates on Diabetes in the United
States, 2007. Available at:
http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf
Accessed February 10, 2010.
62. Hadaegh F, Bozorgmanesh RM, Ghasemi A, Harati H, Saadat N, Azizi F.
High prevalence of undiagnosed diabetes and abnormal glucose tolerance
in an Iranian urban population: Tehran Lipid and Glucose Study. BMC
Public Health. 2008;8:176.
63. West KM. Epidemiology of Diabetes and its vascular lesions. New York
Elsevier, 1978.
64. U.S. Department of Health and Human Services. Healthy People 2010. 2nd ed.
With Understanding and Improving Health and Objectives for
Improving Health. vols. Washington, DC: U.S. Government Printing
Office, 2000.
65. The DECODE Study Group. Age-and Sex- Specific Prevalence of Diabetes
and Impaired Glucose Regulation in 11 Asian Cohorts. Diabetes Care
2003; 26:1770-1780.
66. Jenkins DJA, Kendall CWC, McKeown-Eyssen G, Josse RG, Silverberg J,
Booth GL, Vidgen E, Josse AR, Nguyen TH, Corrigan S, Banach MS,
Ares S, Mitchell S, Emam A, Augustin LSA, Parker TL, Leiter LA. Effect
of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2
Diabetes: A Randomized Trial. Journal of the American Medical
Association. 2008;300(23):2742-2753.
67. Schillinger D, Sarkar U. Numbers Don't Lie, but Do They Tell the Whole
Story? Diabetes Care. 2009;32:1746-1747.

28

68. Miech R, Kim J, McConnell C, Hamman RA. Growing Disparity in DiabetesRelated Mortality U.S. Trends, 1989–2005. American Journal of
Preventive Medicine. 2009;36(2):126-132.
69. Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka,
Keinaonen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen
A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J,
Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J. Prevention of Type
II diabetes in subjects with impaired glucose tolerance: the Diabetes
Prevention Study (DPS) in Finland. Study design and 1-year interim
report on the feasibility of the lifestyle intervention program.
Diabetologia.1999;42(7):793-801.
70. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated
number of adults with pre-diabetes in the US in 2000: opportunities for
prevention. Diabetes Care. 2003;26(3):645-9.
71. Motala AA, Esterhuzen T, Gouws E, Pirie FJ, Omar MA. Diabetes and other
disorders of glycemia in a rural South African community: prevalence and
associated risk factors. Diabetes Care. 2008;31:1783-8.
72. Pan X, Yang W, Li G, Liu J. The National Diabetes Prevention and Control
Cooperative Group: Prevalence of diabetes and its risk factors in China,
1994. Diabetes Care. 1997;20:1664-9.
73. Wild S, Green A, Sicree R, King H. Global prevalence of diabetes: estimates
for the year 2000 and projections for 2030. Diabetes Care. 2004;
27:1047–53.
74. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations
of diabetes mellitus with total life expectancy and life expectancy with
and without cardiovascular disease. Archives of Internal Medicine. 2007;
167:1145–1151.
75. Hanefeld M, Schmechel H, Schwanebeck U, Lindner J. The DIS Group
Predictors of coronary heart disease and death in NIDDM: The Diabetes
Intervention Study experience. Diabetologia. 1997;40:S123–S124.
76. The National Institute of Diabetes and Digestive and Kidney. Available at:
http:/www.nlm.nih.gov/medlineplus/diabetescomplications.html
Accesses February 18, 2010.
77. El Bassuoni EA, Ziemer DC, KolmbP, Rhee MK, Vaccarino V, Tsui CW,
Kaufman JM, Osinski GE, Koch DD, Narayan KMV, Weintraub WS.

29

Phillips LS. The “metabolic syndrome” is less useful than random plasma
glucose to screen for glucose intolerance. Primary Care Diabetes. 2008;
2:147–153.
78. Piche ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S:
Contribution of abdominal visceral obesity and insulin resistance to the
cardiovascular risk profile of postmenopausal women. Diabetes. 2005;54:
770–777.
79. Montonen J, Knekt P, Härkänen T, Järvinen R, Heliövaara M, Aromaa A,
Reunanen A. Dietary patterns and the incidence of type 2 diabetes.
American Journal of Epidemiology. 2005;161(3):219–227.
80. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in nonadipose tissue and lipotoxicity. Physiology and Behavior. 2008;94:
231–241.
81. Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Mølsted-Pedersen L,
Hornnes P, Locht H, Pedersen O, Damm P. Increasing incidence of
diabetes after gestational diabetes: a long-term follow-up in a Danish
population. Diabetes Care. 2004;27:1194-1199.
82. The South Carolina Department of Health and Environmental Control. SC
BRFSS – About BRFSS. Available at:
www.scdhec.gov/ad/administration/library/CR009477.pdf
Acessed July 6, 2010.
83. Groth, MV, Fagt, S, Brøndsted L. (2001). Social determinants of dietary
habits in Denmark. European Journal of Clinical Nutrition. 2001;
55:959–966.

30

Jnk
(+)
Fatty acids

Protosome

Ikk
(+)
Iκ - P
Iκ

(+)

-P

nNF – κB

NF - κB

PKC

Inflammatory
transcripts
Fig. 1 How NF – κB Elicit the Events that Lead to Inflammation Initiated by Fatty Acids
High levels of circulating free fatty acids may activate inflammatory signals. Fatty acids
and fat activate factors that lead to inflammation through IKK and JNK. Once activated
IKK and JNK promote the transcription factor NF - κB, which activate inflammatory
transcripts in the DNA. Iκ - P may be removed by proteasome.
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CHAPTER TWO
DIABETES AND PRE-DIABETES INTERVENTION STUDIES: A REVIEW

Type 2 Diabetes (T2D) is one of the major diseases in the world today and the
prevalence of the disease seems to be increasing at an alarming pace. To combat this
disease there is a need for lifestyle interventions that could be implemented efficiently
and affordably. Following is a review of lifestyle intervention studies conducted in the
US and around the world. The review was used to establish the most effective way of
implementing a diabetes or pre-diabetes intervention. The majority of the interventions
focused on T2D interventions and the rest were targeted to those who had pre-diabetes.
Overall, the risk of developing diabetes was reduced 20% to 58% as a consequence of the
different lifestyle intervention protocols.
Introduction
In this literature review, diabetes and pre-diabetes interventions were assessed to
determine the most effective treatments. The review was limited to articles published
from 2000 to 2009. The review search was performed on General OneFile, Expanded
Academic, Academic OneFile, Academic Search Premier, Medline, and Cinahl Plus. The
included articles were those which had interventions for diabetes or pre-diabetes as the
main focal point. The search terms used were “type 2 diabetes interventions”, “impaired
glucose tolerance”, “impaired fasting glucose tolerance”, and “pre-diabetes
interventions”. Articles which focused more on obesity and cardiovascular interventions
were included in the review only if the primary focus was on diabetes patients or
individuals classified as having pre-diabetes.
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Participants’ Classifications
Participants’ blood glucose status was classified as being “normal” for
participants who had fasting blood glucose levels of <100 mg/dl. Participants were
classified as having pre-diabetes if their blood values were found to have been at the
impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) value. The
classifications were made using one or both of the two blood glucose measuring tests.
The fasting plasma glucose test (FPG) (6.1-7.0 mM/L or 100 and 125 mg/dl) is
administered after an overnight or eight hour fast, and the oral glucose tolerance test
(OGTT) (7.8-11.1 mM/L or 140–199 mg/dl) is used to assess blood glucose levels after
an overnight fast and also two hours after 75g glucose challenge (1, 2). In US studies,
researchers either used the ADA levels (Table 2.1) or followed the World Health
Organizations’ (WHO) (Table 2.2) (3) levels. Studies involving Asians, Asian Americans
and Native Americans used WHO standards. One study used measurements which
followed the Japanese Diabetes Society (JDS) recommendations (Table 2.3) (4).
Analyzed Studies
There were 28 articles included in the final analysis (Table 2.4). The articles were
from studies in the US, Mexico, India, Germany, Finland, Canada, Norway, Austria,
Denmark, Sweden, Israel, Spain, Japan, UK, Australia and China. Some studies (5, 6)
were conducted in more than one country. The international scope of this research
indicates that many countries have realized the importance of finding an effective way of
responding to increasing global diabetes rates fueled by the obesity epidemic (6, 7).
Diabetes continues to increase in all countries and among all groups of people, and it is
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expected to continue to increase worldwide (7). It is now well known that individuals
who have T2D are usually overweight or obese (7). Currently, the diabetes and obesity
rates continue to increase in all nations and all ethnic groups. It is logical to deduce that
we have not been able to produce drugs or a message powerful enough to change the
course of the epidemic or to at least halt its current rate (5, 6, 7). For the current diabetes
trends to change there is a need for serious fundamental lifestyle changes in America and
around the world.
Table 2.4 summarizes the main characteristics from the research articles
reviewed. The table includes: purpose of the relevant intervention, location or country
where the intervention took place, sample size, subject blood glucose status at the
beginning of the intervention (diagnosis), type of intervention used, length of study, and
some of the key findings. More details about each reviewed study are discussed at the end
of the table.
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Table 2.4: Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Citation/
Location
Watanabe M,
2003 (4)

Initial
Subject
Diagnosis
#Prediabetes

Type of
Intervention

Length of
intervention

Sample
Size

Purpose of
Intervention

Educational
counseling

1 year

173

Implement new
dietary
education
program to
reduce plasma
glucose levels

Males
Tokyo,
Japan
Tuomilehto J,
2001 (8)

Prediabetes

Diet1,2 and
physical
activity1

3 years

Diet1 and
exercise2

4 years

Male
=172
Female
= 350

Helsinki,
Finland

Kosaka K,
2005 (10)

Prediabetes

522

458
Males

Japan

35

Key
Findings/
Treatment effects
Lowered energy intake
(P=0.002) and blood
glucose levels (P <
0.001). in the treatment
group

Implement the
Finnish
Diabetes
Prevention
Study
intervention

Average weight reduction
of 3.5 kg (treatment
group) avg 0.9 kg in
control group. Treatment
group -58% reduction in
diabetes risk.

Asses a diabetes
prevention
program aimed
at maintaining
ideal body
weight.

After 4 years diabetes
incidence in control group
was 9.4% and 3% in
intervention group (P<
0.001).

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Laatikainen T,
2007 (11)
Southwest
Victoria and
Southeast
South
Australia
Absetz P, 2007
(12)

Prediabetes

1 year

237
Male
= 88
Female
= 223

Prediabetes

Paijat-Hame
Province,
Finland

Ackermann
RT, 2008 (13)

Diet1 and
exercise2

Prediabetes

Energy
reduction,
increased
fiber intake
and moderate
physical
activity1,2
through
counseling
Diet1 and
physical
activity1,2

1 year

352
Male
=103
Female
= 286

6 and 12
months

92
Male
= 41
Female
= 51

Indiana,
US

36

To test whether
randomized
controlled trials
can achieve the
60% success
rate in a
primary care
facility setting
Determine if the
findings of
diabetes
intervention
studies can be
achieved in a
real world
scenario.

Successful mean weight
reduction of -2.52kg (95%
CI -2.79,-1.98) and 4.17cm 3.16 (95% CI 3.72,-2.60) in waist
circumference

Determine if
YMCA workers
can be trained
to conduct
group
interventions

YMCA weight reduction
of 6% in the intervention
group and 2% in the
control group after 6 mos.
(P<0.001)

Only 20% of participants
reached 4 of 5 goals; and
weight loss physical
activity achieved by fewer
participants

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Li G, 2008
(14)

Prediabetes

Diet1 and
physical
activity1

6 years

The αglucosidase
inhibitor
acarbose

3 years

Metformin
and lifestyle
modification

2.8 years

Male
= 312
Female
= 265

Da Qing,
China

Chiasson J,
2002 (5)
Canada,
Germany,
Austria,
Norway,
Denmark,
Sweden,
Finland,
Israel and
Spain.
Knowler WC,
2002 (16)

Prediabetes

Prediabetes

577

1302
Male
= 695
Female
= 697

3234
Male
= 1043
Female
= 2191

National,
US

37

Assess long
term
intervention
improvements
on diabetes and
microvascular
risk.
Assess acarbose
and placebo as
diabetes
preventatives

Diabetes risk reduced
51% However no
significant difference in
CVD rate 0.96 (95% CI
0.65−1.41)

Determine if
lifestyle and
metformin
interventions
may delay or
prevent diabetes
development.

58 % (95% CI 48%- 66%)
reduction in diabetes in
lifestyle group 31% (95%
CI 17%-43%) reduction in
metformin group.

Acarbose reversed
impaired glucose
tolerance to normal
glucose in treatment group
(P<0.0001). placebo
group developed diabetes
w/in 3 mos

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Kitabchi AE,
2005 (17)

Prediabetes

Metformin
and lifestyle
modification

3 years

Multitherapy

3.2 years*

Male
= 1043
Female
= 2191

National,
US

Orchard TJ,
2005 (18)

Prediabetes

India

3234
Male
= 1043
Female
= 2191

National,
US

Ramachandran
A, 2006 (19)

3234

Prediabetes

Indian
Diabetes
Prevention
Program
(IDPP),
lifestyle
modification
and
metformin in
people with
pre-diabetes

3 years

531
Male
= 421
Female
=110

38

Determine if
Intensive lifestyle
deterioration in
intervention, reduced
insulin
diabetes incidence,
sensitivity and
improved insulin
insulin secretion sensitivity and preserved
lead to type 2
β-cell function
diabetes
Determine
Metabolic syndrome
prevalence of
hazard was reduced by
metabolic
41% in the
syndrome in
treatment group (P<
people with
0.001) and 17% in
impaired
metformin group
glucose
(P = 0.03) in comparison
tolerance in an
with the control
intervention
Lifestyle
Risk reductions in
modification
impaired glucose
and metformin tolerance (IGT) to diabetes
to prevent the
with relative risk
development of
reductions of 28.5 (LS)
diabetes in
and 26.4% (metformin),
people with pre(P = 0.029)
diabetes (IGT)

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Torgerson JS,
2004 (20)

Prediabetes

Multitherapy

4 years

Male
= 1810
Female
= 1467

National,
Sweden

Thamer C,
2008 (21)

Prediabetes

Physical
activity1

9 months

156

9 months

Male
= 61
Female
= 95
136

Tuebingen,
Germany
Stefan N,
2007 (22)

3,277

Prediabetes

Exercise and
dietary1,2

Male
= 63
Female
= 73

Tuebingen,
Germany

39

Determine if
orlistat
supplementatio
n to normal and
pre-diabetes
individuals
would be more
effective than
intervention
alone
Determine
PPARD gene
SNPs influence
on lifestyle
intervention
changes
Determine if
SNPs in
PPARD and
PPARGC1A
influences the
outcome of
physical activity
program

Greater weight loss in
both the orlistat and
normal glucose tolerance
groups compared to the
placebo group
(5.8 vs. 3.0 kg with
placebo)(P < 0.001).

Significant decrease in
body weight, BMI,
visceral adipose tissue,
non-visceral adipose
tissue (P<0.0001 all)
Physical activity had a
significant independent
association in an allele of
SNP in PPARD (P=
0.002) and the allele of
SNP in PPARGC1A (P =
0.005)

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Seidel MC,
2008 (23)
Pennsylvania,
US

BacardíGascón, M
2004 (24)
Tijuana,
Mexico
Kirk A, 2003
(25)

Prediabetes
and
diabetes

Counseling,
diet1 and
exercise1

12 weeks

Diabetes

Physical
activity2

Not stated

Diabetes

Physical
activity2

6 months

Diabetes

Intense
lifestyle,
reimbursedlifestyle and
the usual
diabetes care

1 year

South
Carolina,
US

Assess Group
Lifestyle
Balance (GLB)
intervention
included
counseling, diet
and exercise

Sustained weight
reduction BP(P=0.04)
and waist
circumference(P<0.009)
improvements

Examine
participation of
Females Mexican
migrant women
in physical
activity
Assess the
70
effectiveness of
a consultant
Male
based exercise
= 35
program to
Female
= 35
encourage
physical activity
Implement a
152
lifestyle
intervention
Male
designed for
= 30
Female patients in rural
=122
communities

No significant difference
between activity levels of
insured and uninsured
group

Male
=14
Female
=74

Scotland,
UK

Mayer-Davis
EJ, 2004 (26)

88

40

100

Participants increased
their physical activity
levels (P < 0.001) and
their biochemical
variables.

Reduction in weight
(P<0.01) and glycemia
(P<0.05) in the lifestyle
intervention groups.

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Jenkins JDA,
2008 (27)

Diabetes

Ontario,
Canada

Wolever MST,
2008 (28)

Diabetes

Low glycemic
index diet2
and high fiber
cereals

6 months

Dietary1,2

1 year

210
Male
= 128
Female
= 82

162
Females

Toronto,
Canada

Wolf AM,
2004 (29)
Virginia,
US

Diabetes

Dietitian-led
case
management
lifestyle

1 year

147
Male
= 60
Female
= 87

41

Test effects of
low–glycemic
index diets on
glycemic
control and
cardiovascular
risk factors in
patients with
type 2 diabetes.
Assess efficacy
of glycemicindex
carbohydrate
diets on
diabetes
management
Assess a
diabetes
intervention
program that
can be used for
obese patients

Low glycemic diet
lowered A1c of patients
compared to the high fiber
cereal (P<001)

Not many differences in
diet intervention results,
postprandial glucose and
CRP
were reported to be lower
with low-glycemic index
diet.
Greater weight reduction
in treatment group
(P<0.001),
reduced waist
circumference
(P<0.001), reduced
medication use (P = 0.03).

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Ménard J,
2005 (30)

Diabetes

Multi-therapy

1 year

Male
= 49
Female
= 23

Quebec,
Canada
Corse W, 2007
(31)

Diabetes

Educational
empowerment

1.2 years

58
Male
= 33
Female
= 25

Michigan,
US

West DS, 2007
(32)

69

Diabetes

Behavioral
and
motivational

1.5 years

217
Females

Alabama,
US

42

Evaluate multitherapy vs.
regular care in
people with
poorly
controlled T2D

Intensive intervention
therapy patients met the
goals set by the Canadian
national diabetes
association

Evaluate
effectiveness of
shared decisionmaking (SDM)
goal-setting
intervention

Improvement in A1c,
weight, and diabetes
empowerment score
(P<.001) and patient’s
diabetes knowledge
(P<.001)

Determine if
adding a
motivational
portion to a
weight control
program would
be more
beneficial in
women

Weight reduction
(P =0.04), and glycemic
control (P=0.02), were
attained

Characteristics of Reviewed Diabetes and Pre-diabetes Interventions
Kahn SE, 2006
(6)

Diabetes

Single drug
pharmacother
apy

4 years*

Intensive
drug, diet1
and exercise1

7.8*

160

Intensive1
drug, diet and
exercise1

13.3*

Male =
119
Female
= 41
160

Male
= 2511
Female
=1840

US,
Canada and
Europe
Gaede P, 2003
(34)

Diabetes

Copenhagen,
Denmark
Gaede P, 2008
(35)

Diabetes

4351

Male =
119
Female
= 41

Copenhagen,
Denmark

Assess
effectiveness of
rosiglitazone,
metformin, and
glyburide for
T2D patients.

Rosiglitazone risk
reduction was 32% more
than metformin,
and 63%, more than
glyburide (P<0.001).

Modify CVD
risk factors in
T2D patients

CVD risk was reduced
50% (hazard ratio, 0.47;
95 CI, 0.24- 0.73)

Assess
mortality and
benefit
maintenance
post
intervention

Type of Diet Program: 1-Caloric restriction diet, 2-Increase fruits and vegetables,
Type of Physical Activity: 1-Weight loss physical activity, 2- Regular physical activity.
Type of Exercise: 1-Regular exercise program 2-Moderate intense program.
* The average length of participation for all the participants in the study.
# Definitions used: The Japanese Diabetes Society (JDS) measurements,
LS-Lifestyle Intervention.
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Risk of death reduced
20% in T2D participants
and microalbuminuria
(P = 0.02)

Intervention Studies
Pre-diabetes Studies
In Tokyo, Japan, Watanabe and colleagues (4) studied working men (n = 173)
who had pre-diabetes, or were at high risk of developing diabetes. Pre-diabetes was
diagnosed according to the Japanese Diabetes Society (JDS) standard which defines 1-h
PG values of ≥10 mM/L as “borderline diabetic” (Table 2.3) (4). The researchers
developed a new dietary education (NDE) program which included individualized dietary
counseling. Participants aged 35-70 were randomly divided into two groups: NDE (n =
86), and controls (n = 87) who received standard care. Patient responses to a 65-item
semi-quantitative food frequency questionnaire were the basis for prescribing
individualized diets. Participants in the treatment group received individualized feedback
from their questionnaire responses and were counseled on ways they could best improve
their health by following the recommended guidelines. The counseling session was
conducted a month after the health checkup; six months later the second session was
conducted following another health checkup. The results from the study indicated that an
individualized approach was significantly better than standard care. The intervention
group had lower energy consumption in comparison with the controls, and had a 15.3%,
(P = 0.002) success rate for following the recommended dietary guidelines compared to
6.0% (P = 0.002) in controls. The intervention group had a decreased 2-h PG after 1 year,
while the control group increased, the percentage difference between the two groups was
15.2% (P <0.001) (4).
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In the Finnish Diabetes Prevention Study (DPS) (8, 9), a diet and exercise
intervention was shown to reduce the risk of developing diabetes by 58 % (P<0.001) in
subjects (n = 522) who had pre-diabetes. This ground-breaking, randomized, controlled
study was one of the first to show that diabetes can be prevented through diet and
exercise in people who have pre-diabetes (8). In the DPS, subjects were randomly
assigned to two groups 1) a regular care group (control) or 2) an intensive intervention
group (treatment). Inclusion criteria were based on the following: (1) age 40-64 yrs at
screening, (2) BMI >25 kg/m2 at screening and (3) a mean value of two 75-g OGTTs in
the IGT range based on WHO criteria (8, 9). The treatment group was given the
following goals: reduce weight by ≥5%; moderate-intensity physical activity for ≥30 min
every day; reduce dietary fat energy intake to <30% of total energy (E%); reduce
saturated fat consumption to <10 E%; and increase fiber consumption by ≥15 g/1,000
kcal (9). At year one, average weight was reduced 4.5±5.0kg (5.1%) in the intervention
group (n = 256), compared to an average reduction of 1±3.7kg (1.1%) in the control
group (n = 250) (P<0.0001). At 3 years, results were 3.5±5.1kg (4.0%) for the
intervention group (n = 231) and 0.9±5.4kg (1.1%) for the control group (n = 203),
respectively (P<0.0001). BMI for the 1 year period was reduced on average by 1.6 kg/m2
in the intervention group and by 0.4 kg/m2 in the control group (P<0.0001). These results
were similar at year 3 with BMI reduced 1.3 kg/m2 in the intervention group and 0.3
kg/m2 in the control group (P<0.0001). There were significant improvements in the
fasting plasma glucose -0.2±0.7 mg/dL (P <0.0001), 2-h plasma glucose -0.9±1.9 mg/dL
mg/dL (P<0.001) and the A1c -0.1± 0.7 (P<0.003) in the treatment group (9). It was

45

concluded that the diabetes risk reduction and the improvements in the glucose tolerance
and body weight were a direct result of the lifestyle intervention (8). It is worth noting
that the DPS study was suspended because the diabetes incidence was significantly
(P<0.001) lower in the treatment group than in the control group (8, 9). The DPS and
Diabetes Prevention Program (DPP) studies showed that people with pre-diabetes and
those at risk of developing diabetes can reduce their risk by 58% through lifestyle
interventions.
In a long-term study in Japan, male participants (n = 458) with pre-diabetes were
assigned to a standard intervention group (control group) or an intensive intervention
group (10). The intensive diet and exercise intervention was designed to promote
attainment of an ideal weight indicated by a BMI ≤ 22 kg/m2 (10). Participants in the
intensive treatment group were asked about their diet, advised on ways to reduce caloric
intake and maintain their weight, and asked to participate in physical activity or exercise,
such as walking for 30–40 min per day (10). Control group participants were encouraged
to exercise and diet to avoid weight gain and to attain a BMI ≤24 kg/m2. At year 4
diabetes incidence was 9.4% and 3%, standard vs. intensive intervention, respectively,
(P<0.001) (10). There was a significant difference in weight loss between groups with the
standard intervention group losing -0.39±1.42 kg and -2.1±1.63 kg in the intensive
intervention group (P<0.001) (10). The study was effective in reducing the risk of
developing diabetes. The percentage improvement in impaired glucose tolerance was
53.8% to normal BG values in the improvement intensive intervention group and 33.9%
improvement in the control group (P<0.001) (10).
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In Australia, Laatikainen and colleagues' Greater Green Triangle (GGT) Diabetes
Prevention Project (11) included adults aged 40-75 diagnosed with pre-diabetes or at a
high risk of developing diabetes due to other risk factors. The goal was to determine if it
was possible to attain previous results of randomized controlled trials (8, 9, 10) that had
achieved close to 60% success rate in a primary care facility setting. The GGT trial was
based on the Finnish DPS study (8). The intervention included six motivational sessions
of 90 minutes each, with the first five sessions given within the first 3 months and the
final session given during the eighth month. During these sessions patients were
encouraged to take charge of their diabetes-related conditions and choose the best ways
to reduce the risk of developing diabetes through diet and exercise management. There
was an average improvement of 4.0% in waist circumference, a weight reduction of 2.7%
and BMI reduction of 2.8%. This study achieved less robust results than those seen in
clinical trial interventions; however, it demonstrated that it is possible to achieve a
successful intervention in a primary care facility (11).
Absetz and colleagues (12), conducted a study in subjects (n = 352) aged 50–65,
who had a higher risk of developing T2D (indicated by elevated blood glucose, or lipids,
obesity and hypertension). Subjects were divided into groups and offered either a
counseling intervention or diet and exercise intervention to reduce their risk of
developing diabetes. After 3 years of counseling there were improvements, but the
counseling group results were less than those seen in the diet and exercise intervention
group. The intervention was designed to emulate a real life scenario to provide evidence
that people can do things that may improve their lifestyle and health (12). The study had
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5 criteria set for the participants to reach by the end of the study: (1) <30% of total energy
intake from fat; (2) <10% of total energy intake from saturated fat; (3) ≥15 g of
fiber/1,000 kcal; 4. 4 h/week moderate level physical activity; and (5) >5% weight
reduction (12). The authors reported that 20% of the participants were able to reach 4 of
these goals and in addition some of the risk factors, such as diastolic blood pressure,
weight and waist circumference were reported to have decreased. However, BMI was
decreased in male participants only. While 71 of the participants were able to improve
and reach some of the 5 goals set (average = 3) for the study, there were 281 participants
who did not reach the goals set (12).
The Diabetes Education & Prevention with a Lifestyle Intervention Offered at the
YMCA (DEPLOY) study conducted by Ackermann and colleagues (13), evaluated how
an adapted DPP program would work in a community, or a “real-world” setting (13). The
researchers wanted to assess how the DPP achievements (8) can be attained in a study
conducted by YMCA staff members. To achieve this goal, YMCA staff members were
trained to conduct the study utilizing some of the strategies used by professionals in the
DPP and other similar programs (13). The study paired 92 participants from two YMCA
facilities; 46 received standard advice on diet and physical activity and the other 46 were
enrolled in the DPP (17). After 4-6 months there was a reduction in weight of 2.0 %
(95% CI = 3.3 - 0.6) for the standard advice and 6.0% (95% CI = 7.3 - 4.7) for the DPP
group (P<0.001) (13). There was also a significant reduction in BMI of 2.3 kg/m2 (95%
CI = 3.7 - 0.8) and 5.8 kg/m2 (95% CI = 7.3 - 4.4) in control and intervention groups (P =
0.001). No significant difference in A1c, 0.1 (95% CI = 0.2 - 0.01) occurred at 4-6
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months for either standard advice or DPP groups (P = 0.96). At 6-12 there were BMI
changes of 1.4 kg/m2 (95% CI = 3.6 - 0.8) and 6.7 kg/m2 (95% CI = 9.1 - 4.4) (P = 0.002)
in the standard advice and DPP, respectively. There was no significant change in A1c for
both groups (P = 0.28) (13). There were fewer significant improvements in DEPLOY
participants compared to the DPP and similar programs. It may still be more
advantageous to be enrolled in an intervention run by professionals within a medical or
academic setting as the improvements are significant. However, this study demonstrated
that by training employees to conduct interventions and providing more financial
resources; organizations such as the YMCA can provide additional opportunities for
community-based lifestyle interventions aimed at decreasing the prevalence of chronic
metabolic disorders.
In a 20 year follow up of the participants in the Chinese Da Qing Diabetes
Prevention study (n = 110,660), Li and colleagues (14) measured the impact of
participation in a long term intervention to determine if such intervention had longer term
effects which extended beyond diabetes prevention (14, 15). The participants in the
original study, aged 25-74, were at risk of developing diabetes, and resided in the Hei
Long Jiang Province of China (14). The intervention, which lasted for 6 years, recruited
subjects (n = 577) with pre-diabetes from 33 clinics (14, 15). This diet and exercise trial
was one of the first studies to show that diet and exercise can prevent or delay the onset
of diabetes in people who have pre-diabetes or who are at risk of developing diabetes.
The risk of developing diabetes was reduced by 31% in the diet only intervention group,
46% in the exercise only group, and by 42% in the diet and exercise group (14). After 20

49

years, participants in the diet and exercise intervention group had a risk reduction of 51%
compared to 43% risk reduction after the 6 year intervention. At 20 years, diabetes rates
were 11% in the control group and 7% in the intervention group. Participants in the
intervention group also spent an average of 3.6 fewer years with diabetes when compared
to controls (14). This study showed that participating in a lifestyle intervention program
was far more beneficial and suggested that beneficial effects could last throughout the
participant’s life.
Chiasson and colleagues' Study To Prevent Non-insulin-dependent Diabetes
Mellitus (STOP-NIDDM) (5) was a double-blind, placebo-controlled randomized study
conducted in Canada, Germany, Austria, Norway, Denmark, Sweden, Finland, Israel and
Spain. Subjects with pre-diabetes were recruited from high risk populations defined by
having a BMI of 25 to 40 kg/m2 and being 40 - 70 years old, and patients with an
immediate relative with diabetes. Eligible patients were randomly assigned to either the
placebo or the acarbose treatment. Acarbose is a α-glucosidase inhibitor used to treat
diabetes patients in the US and is used to treat both diabetes and pre-diabetes in some
European countries. Participants met with a dietician and were encouraged to lose weight,
maintain a healthy body weight and participate in regular physical activity. Weight
reduction was modest compared with other pre-diabetes interventions. Average weight
for subjects in the acarbose group slightly decreased from 87.6±15.2 kg to 87.1±15.3 kg,
while average weight increased slightly in the control group from 87.0±14.1 kg at
baseline to 87.3±15.2 kg at 3 years. Diabetes risk reduction was 25% in the acarbose
study. About a quarter of the patients in this study dropped out due to drug side effects.
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Half of those dropped out during the first year, and about 31% were from the acarbose
group compared to 19% from the placebo group. Acarbose increased the reversal of prediabetes to normal glucose state, but the relative risk of developing diabetes was 0.75
(95% CI = 0.63 - 0.9) (P = 0.0015). This meant 32% of the acarbose group and 42% from
the placebo group developed diabetes (5).
Knowler and colleagues' Diabetes Prevention Program Research Group (16, 17)
included pre-diabetic and non-diabetic subjects (n = 3,234) assigned to 3 different
intervention groups; 1) received placebo (n = 1082); 2) received 850mg metformin twice
daily (n = 1073); 3) lifestyle intervention program with goals of ≥7% weight loss and
≥150 minutes of physical activity/week (n = 1079). Lifestyle group subjects were given a
training session to help with adherence to diet, exercise and a healthy lifestyle; while
groups receiving metformin or a placebo had individual 20-30 minute sessions in which
subjects were asked to eat a healthy diet and increase their physical activity (16). Subjects
were ≥25 years. Participants reduced energy by 249±27 kcal, 296±23 kcal and 450±26
kcal in placebo, metformin, and lifestyle groups respectively (P<0.001, all).
There was a difference in the amount of weight lost by the participants in each
group; average weight loss/group was 0.1kg with placebo, 2.1 kg with metformin, and
5.6 kg with lifestyle-intervention (P<0.001, all). Calculated diabetes incidence per group
was 11.1% with placebo, 7.8% with metformin, and 4.8% with lifestyle intervention (16).
The diabetes incidence was reduced 58% (95% CI = 48% - 66%) for the lifestyle group
and 31% (95% CI = 17% - 43%) in the placebo group. Metformin, with a 31% diabetes
risk reduction (16, 17), was a very good intervention medication and was more effective
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than acabose which had a risk reduction of 25% as noted below (21). The study findings
also indicated that metformin and lifestyle intervention were similar in restoring normal
fasting glucose, however, lifestyle was more effective in restoring post load glucose (16).
Pharmacological intervention may be ideal for some patients, but to gain greater risk
reduction it would be advisable for people at risk of developing diabetes to use lifestyle
interventions as the preferred first line of prevention. It must be stated; however, that
pharmacological intervention may be preferable for patients who are not able to
participate in moderate and vigorous physical activity. Metformin was shown to have the
capacity to reduce the fasting plasma glucose by levels close to those of physical activity
during the entire 3 year period of the intervention: This may be promising for impaired
fasting glucose reduction in patients who have difficulty walking (17).
Orchard and colleagues set out to determine the prevalence of metabolic
syndrome in subjects (n = 3234) with pre-diabetes using participants from the DPP study
(18). Participants' risk of metabolic syndrome was reduced by 41% in the lifestyle group
(P < 0.001) and by 17% in the metformin group (P < 0.03) compared with placebo (18).
Results from the Indian Diabetes Prevention Program (IDPP) (19) compared the
effects of diet + exercise to the use of metformin on BMI and A1c. There was a risk
reduction, measured by blood glucose levels and lifestyle changes, of 26.4% in the drug
therapy group compared to a 28.5% risk reduction in lifestyle modification intervention
(19). The A1c for the control group was 6.2±05, 6.2±06 for the metformin group and
6.1±05 lifestyle group with 6.2±0.6 for the lifestyle and metformin combined (P>0.05).
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BMI was 26.3±3.7 for the control group, 25.7±3.3 lifestyle group, 25.6±3.7 for the
metformin group and 25.6±3.3 for lifestyle and metformin combined (P>0.05) (19).
Torgerson and colleagues' The Swedish XENical in the prevention of Diabetes in
Obese Subjects (XENDOS) study was conducted using the diabetes drug orlistat and
lifestyle intervention to prevent the onset of diabetes (20). Subjects were pre-diabetes
patients and those with a high risk of developing T2D. The study was conducted over a 4
year period, was aimed at determining both how effective orlistat was in treating
metabolic disorders and the safety of the drug (20). Study participants (n = 3305) were
randomly assigned to either treatment with orlistat, and the lifestyle changes group (n =
1,650) or the placebo and lifestyle changes group (n = 1,655). At 4 years, both the
Orlistat (n = 1640) and the placebo (n = 1637) groups had lost very few subjects. Patients
in the orlistat intervention had a higher diabetes prevention rate as compared to the
placebo group. The diabetes rate was 9.0% in the placebo group and 6.2% in the orlistat
group and this was translated into a 37.3% decrease in the risk of developing diabetes
with orlistat (P = 0.0032) (20). At one year there was a weight reduction of 10.6 kg in the
oristat group compared to a mean weight loss of 6.2 kg for the placebo group (P<0.001);
and 5.8 kg compared to 3.0 kg weight reduction at the end of the study for the orlistat and
the placebo groups, respectively (P<0.001).
In a study of 156 pre-diabetic and non-diabetic participants, Thamer and
colleagues reported that the hormone receptor, peroxisome proliferator-activated receptor
(PPAR)-δ was a significant factor in how much benefit an individual would gain from a
lifestyle intervention program (21). Thamer and colleagues had previously demonstrated

53

that a single nucleotide polymorphism in the PPRD gene was corrected to predict how a
subject would respond to diet and physical activity lifestyle intervention (22). This
polymorphism to insulin sensitivity and the rate at which skeletal muscle would burn
fatty acids during an aerobic activity (21, 22). The study included parts of the DPP
program, including a weight reduction of 7% and an increase of at least 150 min/week in
physical activity (21). They also recommended that participants reduce their saturated fat
intake, and increase daily fiber intake and physical activity (21, 22). In the current study
(n = 156), 27% of subjects had impaired glucose tolerance, and none had diabetes. By the
end of the study, one subject had developed diabetes, and 123 (79%) had normal glucose
tolerance. Only 32 (21%) still had impaired glucose tolerance. After nine months of
physical activity and dietary and lifestyle intervention there were significant
improvements in insulin sensitivity from 11.8 U/kg at baseline to 13.4 U/kg at follow-up
(P <0.01). The fasting glucose levels remained the same at 5.2 mM/L (P<0.07) before
and after the intervention while the 2-h glucose (OGTT) improved from 6.7 to 6.3 mM/L
(P<0.01). The subjects also had significant improvements in body weight, averaged 86.3
kg (95% CI = 52.5 - 124.7) at baseline, and had an overall weight reduction to 84.0 kg
(95% CI = 53.3 - 121.8) (P<0.0001). Another significant improvement was noticed in the
BMI, which initially was 29.0 kg/m2 (95% CI = 19.4 - 43.5), and by the end of the study
was reduced to 28.0 kg/m2 (95% CI= 18.6 = 39.4) (P<0.0001). Thamer stated that
increasing muscle volume and reducing body fat were important for maintaining a
successful and effective lifestyle intervention (21).
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In the Seidel study, subjects (n = 88) from an underprivileged urban setting with
diabetes or pre-diabetes were enrolled into a Diabetes Prevention Program. The authors
tested the hypothesis that a successful group lifestyle balanced intervention for
individuals with metabolic syndrome could reduce the prevalence of diabetes (23). The
intervention included attending group classes, choosing healthy foods, reducing fat and
calorie intake and using a pedometer. The 12-14 week study was comprised of 12 weekly
sessions. Subjects were given local gym memberships, and provided a pedometer and a
fat calorie counter. Subjects monitored their food intake and physical activity, and were
given real time feedback on results of the program. At 3 months (12 weeks), 46.4%
reported a weight loss of ≥5%, and at 6 months, 66.7% retained the body weight loss.
Assessment of metabolic syndrome status resulted in ≥1 metabolic syndrome component
improved in the 30 subjects (43.5 %) who submitted their data for review (23).
Diabetes Studies
In Mexico, Bacardı´-Gasco´n et al. conducted a physical activity study of women
(n = 100) in the migrant working communities (24). Subjects were assigned to the
uninsured (n = 37) and the insured (n = 63) groups. Participants attended 1 hr exercise
counseling and were given physical activity leaflets. They also attended a 30 min group
exercise which included strength training, flexibility and aerobic exercises. Participants
were then encouraged to exercise 20 min during the week. There were no differences
between insured (1.53±0.03) and uninsured (1.56±0.04) groups in their levels of
participation in both outdoor and indoor physical activity (P = 0.5) (24).
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A study conducted by Kirk and colleagues attempted to devise ways to encourage
physical activity in T2D patients (n = 70) over a 6 month period. Participants were
assigned to two groups of 35 each with the treatment group given a physical activity
consultant while the control group had no consultant. The exercise consultant met with
each participant individually and helped him/her make proper adjustments aimed at
changing to a more physically active lifestyle (this included 30 min physical activity for
most days of the week). The adjustment was done in 5 stages of behavior change (precontemplation, contemplation, preparation, action and maintenance). Some of the
strategies included encouraging participants to increase physical activity and reduce
relapse. After 6 months the activity per week was different between the groups (95% CI =
594,501 - 1,723,539) and (95% CI = -1,786,768 - -491,490) for counted activities per
week as measured by CSA uniaxial accelerometer (25). Patients in the treatment group
had a 7.2x increase or 128 min of moderate activity per week (95% CI = 85.0 - 182.5)
and a 7.6x increase or a 153 min of moderate activity per week (95% CI = 112.5 - 207.5)
(25).
Mayer-Davis and colleagues developed the POWER (Pounds off with
Empowerment) diabetes intervention study, conducted for 12 months in rural South
Carolina for low income T2D patients at rural health care centers (26). Subjects had
diabetes, were aged ≥45 years, and had a BMI of ≥25 Kg/m2. Participants were randomly
divided into 3 groups: intensive lifestyle intervention, reimbursable-lifestyle intervention,
or usual care (26). The structure and design of the intervention were influenced by the
DPP (14) with the aim of attaining ≥10% weight loss by reducing dietary fat intake to
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<25% of caloric intake and maintaining 150 minutes of moderate physical activity/week.
The POWER study produced modest results for both men and women at 3 and 6 months
(P>0.05). There was a gender difference at 12 months; women had a mean weight loss of
1.5 kg while men had a mean weight loss of 4.7 kg (P = 0.02). The study had a high
number of African American women and the weight loss in this group was lower than
that attained in other groups and other intervention studies (7, 14). The researches in the
POWER study cited reasons participants had given as obstacles to behavioral change,
which included caring for family members, feeling exhausted and being anxious about
diabetes (26).
A study in Canada by Jenkins and colleagues (n = 210) (27) was designed to test
the effectiveness of a low-glycemic index diet compared to a high-cereal fiber diet in
controlling blood glucose and cardiovascular disease risk factors. A1c was used as an
indicator of chronic blood glucose elevation in participants with T2D. Subjects were
randomly assigned to either the low-glycemic index or high-cereal fiber group. Fiber
intake was different between the treatment group (low-glycemic index) and the control
group (high-cereal fiber) group. Fiber increased in the low-glycemic index diet group
(18.7 g/1000 kcal at week 24) in comparison with the high-cereal fiber diet (15.7 g/1000
kcal at week 24; P<0.001). A1c decreased 0.50% (95% CI = –0.61% - –0.39%) with the
low-glycemic index diet and 0.18% (95% CI = –0.29% - –0.07%) with the high-cereal
fiber diet. This indicated that those in the low-glycemic index diet had a more positive
outcome in comparison with those who consumed a high–cereal fiber diet. The reduction
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of the glycemic index indicated that there was a positive correlation with reducing the
A1c (r = 0.35, P<0.001) (27).
The Canadian Trial of Carbohydrates in Diabetes (28) was a 1 year diet-only T2D
management study conducted by Wolever and colleagues. The study was aimed at
assessing the effects of carbohydrates on A1c, blood glucose and C-reactive protein
(CRP) based on the source and amount of carbohydrates consumed (28). Participants (n =
162), who managed diabetes with diet only, were randomly assigned to a highcarbohydrate, high-glycemic index (high-GI) diet (n = 52), high-carbohydrate and lowglycemic-index (low-GI) diet (n = 56), or low-carbohydrate, high-monounsaturated-fat
(low-CHO) diet (n = 54) (28). Participants were assigned key foods to help adherence to
the prescribed diet, had help from a dietician, and were allowed to continue taking their
diabetes medications. At one year, carbohydrate energy contributed 47% for the high-GI,
52% for the low-GI, and 39% for the low-CHO group (28). The energy from fat was 31%
for the high-GI, 27% for the low-GI, and 40% for the low-CHO diet group. The GIs for
the three diet groups were 63, 55, and 59 for the high-GI, low-GI and low-CHO
respectively (28). The A1c declined at the beginning for the low-GI diet (P=0.084), and
in the same way fasting plasma glucose declined at the beginning for the low-GI and lowCHO diet groups. These benefits, however, were erased by the end of the study period at
which time the high-GI diet group had the lowest fasting plasma glucose. With no
differences between the groups, however, the A1c for both groups combined increased
from approximately 6.1 at the beginning of the study to approximately 6.3 by the end of
the study (P<0.0001) (28). There was some weight loss at the beginning in the low-GI
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diet group and some weight gain towards the end of the study period for the low-CHO
diet group and both were insignificant (28). There were differences in the effects of diet
on CRP between the low-GI group (P = 0.0078) and the high-GI diet group (P<0.05)
with the CRP of the low-GI group being less than that of the high-GI group. CRP had a
reduction of >20% which was sustained throughout the study (28).
In the Improving Control with Activity and Nutrition (ICAN) study (29), Wolf
and colleagues utilized a case management-based intervention for diabetes patients. The
randomized controlled study had a registered dietician as case manager for diabetes
patients. The participants were assigned into two groups, the regular care or the dietician
case management group. All patients continued to receive their regular care during the 12
months intervention period. A $350 per person fee was required for diabetes patients
assigned to receive professional help from a registered dietician. Patients in the regular
care group were free to join any diabetes or weight management programs. The
researchers assessed how effectively the dietitian-led intervention would work, and how
economical it would be in a primary care environment compared to the usual care. At 12
months the intervention group had lost an average of 2.4 kg, while those in the usual care
group had gained on average 0.6 kg. The intervention group lost 5.5 cm in waist
circumference while those in the usual care group had only lost 1.4 cm. There was a
difference, in blood glucose levels, between groups as measured by A1c (P = 0.02).
Patients who received counseling and education from the dietician had a significantly
improved health outcome compared to those who received the regular protocol (P < 0.05)
(29).
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A Canadian study by Ménard et al. assessed whether a multi-therapy intervention
had an improved effect on fasting plasma glucose levels and A1c concentrations. The
multidisciplinary team set out to determine whether such benefits would be maintained
for up to 6 months after the 1 year intervention had been completed (30). T2D patients (n
=72) with ≥8% A1c concentration were put into either usual care (control group) or into
the multi-therapy intervention group. Baseline A1c for the intervention group was
9.1±1.0 and 9.3±1.0 for control group and 7.5±1.0 for the treatment group at 12 months
compared to 8.61±0.3 for the control group. At the 18 month follow-up, it seemed that
the benefits of the intervention were diminishing as A1c for the intervention group was
8.1±1.2 compared to 8.6±1.3 for the controls. At 18 months there were no significant
difference between groups and most of the benefits attained at 12 months had vanished
for the intervention group (30). Similar to A1c, the fasting plasma glucose at beginning of
the study was 10.8±3.5 mM/L for the intervention group and 10.7±3.0 mM/L for the
control group. At 12 months the intervention group had fasting plasma glucose of 8.2±2.8
mM/L compared to 9.8±2.7 mM/L for the control group. At 18 months the benefits of the
intervention were again eroding as the intervention group had 8.7±2.5 mM/L compared to
9.6 ±3.5 mM/L in the control group (30).
Corse and associates (31) enrolled 58 diabetes patients in a shared decisionmaking model. In this model, patients and their primary care provider together decide the
best way to improve the patients’ diabetes knowledge and care. Patients attended a 2-hr
educational session in which patients were helped by their primary care provider in
setting individual goals and also provided some supportive reading materials. In the 10
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workshops and sessions, patients were asked to determine what was important to them
about their conditions, and what would be a priority in easing their conditions. Study
results were disappointing, perhaps due to small sample size. A1c values (n = 33),
decreased slightly from 7.94±1.49 to 7.62± 1.92 (P = 0.222). The average body weight (n
= 38) was 228.21±55.11 lbs. and 225.48±55.09 lbs (P = 0.222), initial and final,
respectively. Significant improvement in diabetes understanding was observed using a
Diabetes Attitude Scale of 1-7 (1 = poor; 7 = excellent understanding), pre-intervention
and post-intervention averages were 4.35±1.46 and 5.42±1.27 (P<.001) (31). However,
this intervention may not be feasible for some patients as it depends heavily on the
cooperation of the physician and the ability of the patient to pay for extra services
needed. For a successful intervention a low income patient may need the financial
resources to pay for required extra services. As a result, this type of intervention may not
be readily available to the greatest percentage of at-risk subjects.
West and colleagues (32) used motivational interviewing to encourage female
subjects (n = 217) with T2D to lose weight and improve their blood glucose levels.
Participants were assigned to a motivational interviewing or a control group. At 6 months
the intervention group had a significantly greater mean weight loss (4.7±0.45 kg) when
compared to control (3.1±0.47 kg) (P=0.01) (32). Participants in the intervention group
began to regain weigh after 12 months, while the control group began to regain weight
after 6 months. These results suggest that there may be a need to change the intervention
every 6 to 12 months to avoid weigh regains. A1c was 8 ±0.1 in the treatment group and
7.1 ±0.1 for the control group (P = 0.02) at six months, at 18 months A1c was equal

61

between the groups (7.4 ± 0.11). This could imply that the benefits of the intervention
were too small for the A1c levels to be significantly different between the groups
A Diabetes Outcome Progression Trial (ADOPT) (n = 4127), developed by Khan
and colleagues (6), was a large study with participating scientists in 15 countries in
Europe, the US, and Canada. The collaborative intervention evaluated the efficacy and
effectiveness of several diabetes drugs. The diabetes dugs rosiglitazone, metformin, and
glyburide were given to diabetes patients who had not been treated with other diabetes
drugs. The drugs were thought to have failed if the blood glucose levels were >180
mg/dL (>10.0 mM/L) after an overnight fast. A positive outcome was a fasting plasma
glucose level <140 mg/dL (7.8 mM/L) after drug therapy. Diabetes patients were
randomly assigned to three groups; rosiglitazone (n = 1393), metformin (n = 1397), and
glyburide (n = 1337). Participants received the drugs in identical capsules, with dosages
increasing over time. Using the >180 mg/dL fasting blood glucose standard set as a drug
theraputic failure, 143 patients in the rosiglitazone group “(2.9 per 100 patient-years)”
fell in this category and 207 in the metformin group “(4.3 per 100 patient-years)”, while
311 patients in the glyburide group “(7.5 per 100 patient-years)” were in this category.
The incidence occurrence measured using the Kaplan–Meier distribution was 15%, 21%
and 34% for rosiglitazone, metformin, and the glyburide groups, respectively. The
secondary drug outcome measured a <140 mg/dL fasting plasma glucose progression
rate. For patients assigned to the rosiglitazone group the rate was 79 of 511 participants.
Metformin group rate was 127 of 520 with risk reduction of 36% (95% CI = 15 - 52) (P =
0.002) and the glyburide group was 160 of 480 participants with risk reduction of 62%
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(95% CI = 51 - 72) (P<0.001). After 4 years of treatment 1456 (40%) patients in the
rosiglitazone drug group had A1c level of less than 7%, in comparison to 1454 (36%) for
the metformin group (P = 0.03) and 1441 for the glyburide group (26%) (P<0.001). A1c
was significantly different between groups (95% CI = 0.49 to 1.9) (6).
In the Danish Steno-2 Study (n=160), Gaede and co-workers (33) recruited T2D
patients with microalbuminuria who were treated for an average of 7.8 years.
Participants were randomly assigned to either the conventional therapy or the intensive
therapy. Study goal for the intervention group was to achieve: A1c <6.5%, <75 mg/dL
(4.5 mM/L) total cholesterol, <150 mg/dL (1.7 mM/L) triglycerides, <130 mm Hg and
<80 mm Hg for the systolic and diastolic blood pressure respectively (33). Patients in the
intervention group were given blood pressure treatment drugs and a low dose of aspirin
(33, 34). At the conclusion of the study changes in BMI were not significant. BMI change
of males was 0.4±0.4 kg/m2 for conventional therapy and 0.7±0.4 kg/m2 for intensive
therapy (P=0.61), while females’ change in BMI was 1.3±1.3 kg/m2 for conventional
therapy and 2.3±1.2 kg/m2 for intensive therapy (P = 0.29) (34). Fasting plasma glucose
with conventional therapy decreased by 18±11 mg/dL; with intensive therapy it
decreased by 52±8 mg/dL (P <0.001). A1C with conventional therapy increased by
0.2±0.3 and decreased 0.5±0.2 in intensive therapy (P <0.001). By the end of the 13.3year follow up the two groups (total n = 93) seemed to be similar with regard to both
clinical and biochemical variables. Of the 160 diabetes patients who started the
intervention, nine patients in the intervention group died from cardiovascular
complications compared to 19 patients in the control group (P = 0.03) (34). Unlike the 20
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year follow up of the Chinese Da Qing Diabetes Prevention study (15), the benefits
attained through this intervention seem to have been reversed at the 13.3 years follow up.
There were no significant differences between the groups in regard to physical activity,
body weight and waist circumferences, but there were some significant differences in fat
and carbohydrate intake (34).
Conclusion
Of the 28 studies reviewed the average length of study was approximately 2 years,
however the median length of the studies was 1.4 years. In 15 of the studies reviewed, the
subjects had pre-diabetes, while 12 studies were primarily for diabetes patients and one
study had participants who had diabetes or pre-diabetes. This review included studies
utilizing different types of interventions, including 13 using diet, 13 using physical
activity, 8 using drug interventions and 5 studies using education/counseling. Studies
conducted for an average length of 1 year showed a large improvement in the health
status of participants. The greatest improvements were found in studies which combined
physical activity and diet interventions (8, 20). Participants in studies lasting more than
one year showed similar benefits during the first year; however, most of the benefits
seemed to be reversed after the first year (8, 10, 14). This was the case particularly for
weight regain. There may be a need to change the intervention structure every 6 to 12
months to avoid weigh regains. This could also be achieved by the implementation and
emphasis of a weight loss maintenance program after the desirable weight loss is
achieved.
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The Danish Steno-2 Study (33) indicated that it is best to prevent diabetes from
occurring rather than to wait and treat the disease and as can be seen in the follow up at
13.3 years the benefits of the intervention seem to have disappeared. Even prescription
drugs taken resulted in no significant difference in the outcome, with an average of 5.5
medications in the intervention group and 5.7 in the control group (P = 0.64). The study
strengthens the case that lifestyle intervention through diet and exercise is the best way to
delay or prevent the onset of T2D in adults. In the DPP study (16), the metformin group
had a risk reduction of 31 % compared to 58% in the lifestyle group. This was an
indication that even though metformin is a powerful diabetes medication, it is better to
implement lifestyle changes and prevent the onset of the disease. Preventative
intervention offers the best solution not only for diabetes but also for other related
metabolic and chronic diseases such as cancer, cardiovascular disease, stroke, etc (14, 18,
29, 33).
Lifestyle interventions were shown to improve health and to reduce the diabetes
risk in all the reviewed studies. Studies were conducted in different countries around the
world, indicating the global nature of the disease. The Da Qing follow up (14) study
demonstrated the potential benefits for people who are at risk of developing diabetes to
participate in interventions as the long term gains of doing so could extend far beyond the
intervention period. The best improvements and diabetes risk reductions (measured by
fasting plasma glucose, A1c and BMI) were found in participants who had diabetes risk
factors and those with pre-diabetes. Those who already had diabetes seemed to have
minor death risk reduction of 20% in one study (35) vs a 28.5% (19) and 58% (8)
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diabetes risk reduction for those who did not have diabetes at the beginning of the
intervention. One study (26) demonstrated that in a multiethnic country such as the
United States healthcare providers need to be sensitive to the needs of people of different
cultural backgrounds. For studies like this to attain a high success rate, clients’ different
socioeconomic and cultural needs must be taken into consideration. An individualized
diet recommendation can be an effective means to encourage people at risk of developing
diabetes to reduce their levels of blood glucose and delay the onset of diabetes. The
success of the individualized dietary recommendation used in Japan (4) further supports
this approach. In the future it may also be advisable to find ways of addressing some of
the factors that were reported (26) as being barriers to participating in intervention
activities. Thus, a community collaborative effort can reduce the burden on mothers who
have to be caregivers to multiple family members. Another outcome of this study was
that increased participation was achieved by providing transportation for some patients,
while others were given intervention material though teleconference. If many
participants are faced with the same problems/barriers, it may be beneficial to organize
them into groups that share similar experiences and in that way they may find a common
solution to problems.
To improve the general health of the population it is imperative that blood glucose
levels are tested regularly and that the appropriate therapies are offered to those who need
them. It would be beneficial for people who are at high risk of developing diabetes to be
physically active and eat a proper diet.
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Table 2.1 American Diabetes Association criteria for the Diagnosis of Normal
Blood Glucose Values, Pre-Diabetes and Diabetes
Blood Glucose

Normal
Pre-diabetes
Diabetes

Fasting Plasma
Glucose
(mg/dl)1
<100
100 – 125
≥126

2-hr Plasma
Glucose
(mg/dl)2
<140
140 – 199
≥200

A1C
(%)3

Random4
(mg/dL)

<6
5.7 – 6.4
≥6.5

≤125
≥200

1.

Fasting values are defined as 8 hours with no caloric intake.
The test should use the World Health Organization criteria using a glucose load equivalency of 75 g anhydrous
glucose dissolved in water.
3.
Test should use a certified National Glycohemoglobin Standardization Program (NGSP) protocol that is standardized
to the Diabetes Control and Complications Trial (DCCT) assay.
4.
Random or casual blood glucose values are collected regardless of fasting/fed state or time of day.
2.

Table 2.2 World Health Organization Definitions and Diagnosis of Diabetes
Blood Glucose Fasting Plasma
2-hr Plasma
A1C (%)3
1
2
Glucose (mg/dl)
Glucose (mg/dl)
Normal
<100
<140
<6
Pre-diabetes
110 – 125
140 – 199
Diabetes
≥126
≥200
≥6.5
1.

Fasting values are defined as 8 hours with no caloric intake.
The test should use the World Health Organization criteria using a glucose load equivalency of 75 g anhydrous
glucose dissolved in water.
3.
Test should use a certified National Glycohemoglobin Standardization Program (NGSP) protocol that is standardized
to the Diabetes Control and Complications Trial (DCCT) assay.
2.

Table 2.3 Japanese Diabetes Society Definitions and Diagnosis of Diabetes

Normal
Borderline
Pre-diabetes
Diabetes

Fasting Plasma
Glucose (mg/dl)1

1-h Plasma
Glucose (mg/dl)2

<100
110 – 125
≥126

≥180
-

1.

2-hr Plasma
Glucose
(mg/dl)3
<140
140 – 199
≥200

A1C
(%)4
<6
≥6.5

Fasting values are defined as 8 hours with no caloric intake.
1-h Plasma Glucose according to the Japanese Diabetes Society (JDS) standard definitions.
3.
The test should use the World Health Organization criteria using a glucose load equivalency of 75 g anhydrous
glucose dissolved in water.
4.
Test should use a certified National Glycohemoglobin Standardization Program (NGSP) protocol that is standardized
to the Diabetes Control and Complications Trial (DCCT) assay.
2.
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CHAPTER THREE
CU4HEALTH STUDY

Abstract
The purpose of this study was to assess the nutrition-related health behaviors and
diabetes knowledge of employees at Clemson University who had already shown interest
in their health status by their participation in the CU4Health program. CU4Health is the
Clemson University Worksite Wellness Screening Program which is provided to
Clemson University employees, in partnership with the South Carolina Employee
Insurance Program. Invitations were sent to the CU4Health participants to take part in
three online questionnaires: 1) demographic; 2) diabetes knowledge; and 3) food intake
patterns. The surveys included the Michigan Diabetes Knowledge Test, the Block Food
Frequency Questionnaire and a demographic questionnaire. The objective was to
compare the results from the college degree-holding participants and those with less than
a college degree. There were different response rates for the three questionnaires, with
the Diabetes Knowledge Test receiving the highest number of participants. A total
number of 50, 46 and 40 participants completed the Diabetes Knowledge Test, the
Demographic Questionnaire and the Block Food Frequency Questionnaire, respectively.
There were no differences between the mean responses of those with a college degree and
those without college degree (P = 0.4921).
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Introduction
Diabetes
According to the American Diabetes Association, 8% of the population of the US has
diabetes and the total prevalence of diabetes increased 13.5% from 2005 to 2007 (1). In
2007, the CDC reported that about 23 percent, or 12.2 million, of those aged 60 and over
in the U.S. had diabetes. They also estimated that, in this time frame, about 536,000 new
cases appeared among that age group (2). In 2008, the CDC reported that Type 2 diabetes
(T2D) had increased 90% since 1997 and that about a third of those with diabetes don't yet
know they have this dangerous disease (3). In this report, it was stated that South Carolina
diabetes rates increased by 113%, from 1995-1997 to 2005-2007. Of the 33 states
surveyed by the CDC for T2D, South Carolina had the second highest prevalence (3). T2D
affects certain groups more than others. Individuals with close relative who have diabetes,
those who are older than 45 and obese individuals are at a greater risk of developing
diabetes (2). Minority groups such as Native Americans, African Americans,and
HispanicAmericans are disproportionately affected by diabetes (3)
Pre-diabetes
People who have pre-diabetes are particularly at risk of developing diabetes. More
than 60 million Americans are estimated to have pre-diabetes, defined by impaired
glucose tolerance (IGT) or impaired fasting glucose (IFG) (4). According to the ADA, a
person who has fasting plasma glucose of at least 100 mg/dl (5.6 mM/L) but less than
126 mg/dl (7.0 mM/L) is classified as pre-diabetic (1). It would be desirable for people at
high risk of developing diabetes to take early preventative measures so that they may
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delay the progression of pre-diabetes into T2D (5, 6). However, many people do not get
treatment until they already have developed the disease and, by that time, the treatment
options for T2D are limited or less effective (7). As there is no cure for diabetes, it is
important that people are made aware of the complications associated with diabetes
especially as prevention of the disease is the best option (7, 8). In the process of
identifying those with pre-diabetes, Benjamin and colleagues predicted that additional
millions of people with undiagnosed diabetes would be identified as well (9).
In response to increasing healthcare costs, along with the increasing prevalence of
diabetes, Cousineau et al. initiated a 2008 Online Worksite Nutrition Program from
which they concluded that both the private and public sectors are aware of the need for
worksite interventions to prevent chronic metabolic conditions (10). Diabetes is known to
develop along with other chronic conditions such as cardiovascular disease. It, along with
another causative factor, obesity, may also contribute to the development of hypertension,
dyslipidemia and increased need for medical amputation (11, 12, 13, 14). Therefore, there
are many reasons to work toward prevention for those who are at risk.
CU4Health
Clemson University is a public university in Upstate South Carolina that employs
4,909 people, 50.8% male, 49.2% female (15). Of these, the majority are Caucasian
(84.21%), followed by African American (10.21%), Asian (04.01%), Hispanic (1.22%),
Native American (0.122%) and individuals who listed their race as unknown (0.22%).
The Clemson University Worksite Screening Program (CU4Health) is an
employee wellness screening program initiated in 1998 for Clemson University
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employees at the Joseph F. Sullivan Center, in partnership with the South Carolina
Employee Insurance Program (16). The CU4Health program is provided at a low cost and
is available to all the Clemson University employees. The Sullivan Centre health
professionals, who administer the program, assess health risks in individuals by
measuring height, weight and other parameters which include blood pressure, blood lipid
profile, and a blood chemistry profile hemogram (16).
The CU4Health program uses the Personal Wellness Profile (PWP) provided by
Wellsource, Inc. (Clackamas, OR) to determine an overall wellness score for each
participant based on the person’s data, which indicates the general condition of the
patient’s health. Information from the PWP and a follow-up counseling session are made
available to each participant (16). The areas that are discussed during the counseling
session include the patients’ overall fitness which is based on their “cardiovascular
endurance, or aerobic fitness, flexibility, strength and BMI” (16). The patients are
encouraged to exercise regularly and exercise tips are provided for patients who have not
been exercising regularly (16). Another area that is discussed is the patient's risk for
developing heart disease. The score given could be influenced by “smoking, cholesterol,
blood pressure, exercise, diabetes risk, and the patient’s BMI as well as other blood tests”
(16). Each health-related topic is discussed with the patient and appropriate
recommendations made.
The nutrition score on the PWP reflects how well the patient follows the food
guide pyramid, low-fat meals, high-fiber foods, fast food/snacks, and breakfast daily (16).
Other areas included in the counseling session are substance use, coping with stress,
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cancer risk, and osteoporosis. The counseling session helps to determine if there are areas
that need follow-up and what the patient should do to make improvements (16).
By April 2009, the CU4Health program had 1321 names on file of individuals
who had enrolled between October 1998 and April 2009. In 2008, an assessment of the
CU4Health data collected by the Sullivan Centre at Clemson University was undertaken.
The data of the 1321 patients in the CU4Health program indicated that 322 individuals
(25.7%) had a BMI ≥30, classified as being obese, while 800 CU4Health patients were
overweight or obese with a BMI of≥25.
Subjects and Methods
Subject Selection
A review of the CU4Health records revealed that 826 (63%) of CU4Health
participants were at risk of developing diabetes. After this review, it was decided that it
would be better to develop a survey assessment and make it available to the CU4Health
participants. This would provide an idea as to how many of the 1321 participants who
had participated in the program at any time from 1998 to 2009, and were still on campus,
would be willing to participate in a diabetes and wellness-related study.
Subject Recruitment and Participation
Of the identified potential participants, 861 had a valid Clemson University email
as of May, 2009; a Sullivan Center employee contacted these CU4Health participants and
invited them to participate in the study. Invitations were extended by email. The
CU4Health participants who responded were asked to participate by filling in 3 survey
questionnaires. Those who chose to participate were provided a link to the website which
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provided more information on accessing the questionnaires. Participants were given two
options for participation: 1) complete the questionnaires and grant access to their
CU4Health clinical data [clinical data included health and diet history plus height,
weight, BMI, blood pressure, Blood Lipid Profile (cholesterol values and triglycerides);
and Blood Chemistry Profile including blood glucose (blood sugar) and electrolytes as
well as demographic information] or 2) complete the 3 questionnaires without giving
access to the clinical data.
Questionnaire Selection and Administration
Questionnaire Determinants
The questionnaires used were chosen to assess the eating patterns and behaviors
of CU4health participants, with particular interest in what participants consumed during
the past year. The food frequency questionnaire method has been shown to be the most
effective research method for determining the types of food the participants consumed
during the past 12 months (17). To achieve this, a validated full length 2005 Block Food
Frequency Questionnaire (FFQ) (18, 19) was used. A demographic questionnaire, the
Michigan Diabetes Knowledge Test (MDKT) and the Block FFQ provided by
NutritionQuest (Berkley, CA) (an organization that provides nutrition and physical
activity assessment and behavioral support to many universities and research
organizations, including NASA) (20) were used.
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Questionnaires
Michigan Diabetes Knowledge Test
The MDKT is validated to reliably assess diabetes knowledge, and is used
primarily for those who have diabetes (21). The test, developed by the Michigan Diabetes
Research Training Center (Ann Arbor, MI), can be administered in a 14 question short
version which is specific for diabetes patients who do not use insulin or those who have
T2D, and takes about 15 minutes to complete (21, 22).
Block Food Frequency Questionnaire
The Block FFQ, a 110 food-related item questionnaire that was originally
developed from NHANES 1999-2002 (23) was used. This questionnaire provides nutrient
and food group data about the foods habitually consumed by the participants (24). The
electronic version of the 2005 Block FFQ was used, which is estimated to take 30-40
minutes to complete. It can be self-administered and can minimize variability by
assessing foods consumed over a year. The electronic version of the Block FFQ was ideal
for this website-based study.
Demographic Questionnaire
The demographic questionnaire was designed by a co-investigator. The questions
included categories such as gender, age, race, marital status, occupation, and household
income. The questionnaire had a total of 17 questions.
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Questionnaire Administration
Website Design and Content
A website was designed for the purpose of administering the on-line surveys
(Appendix A). The website contained a welcome message and participant instructions.
An informed consent document and the three online surveys were posted on the website
which was accessible to CU4Health employees only. The MDKT and demographic
questionnaires were accessible from the first website and were hosted by Zoomerang
(available at www.Zoomerang.com). A link, provided at the bottom of the first website,
opened a second website, which contained instructions for participation in the FFQ. The
second website provided the username and password required for the FFQ and had a link
to the NutriQuest 2005 Block FFQ.
Questionnaire Completion Procedures
The participants were given a choice to either fill in the questionnaires only, or to
fill in the questionnaires and also allow access to their CU4Health medical history data
by the principle investigator and collaborators. Those who chose the second option were
provided with a consent form to download, print and complete permitting access to their
clinical data. Signed consent forms were delivered via Clemson mail or in person to the
principle investigators. Only individuals with signed consent forms were included in the
CU4Health medical history data protocol. The protocol for the study and consent form
were approved by Clemson University Institutional Review Board.
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Statistical Analysis
Data were compiled and entered in an Excel 2007 spreadsheet. The analysis was
performed using SAS 9.13 (SAS Institute, 2001). Level of education was used as an
independent variable and dependent variables of interest were compared between
educational levels. Pearson product-moment correlations were performed for a subset of
variables at the significance of α=0.05.
A multiple linear regression analysis was also performed on the demographic
data, as well as clinical and nutritional variables. The stepwise multiple linear regression
was used to develop a model for the diabetes knowledge score based on demographic
variables. A second model which included the clinical variables also was developed.
Variables of interest were chosen based on their relationship with the MDKT score. A
comparison was made for the 25 participants who allowed access to their clinical
CU4Health values and some of the values they reported in the study.
Results
Questionnaire Completion Results
Of the 861 emails sent to CU4Health participants to invite them to participate in
the study, approximately 100 emails were sent back as “Invalid users”, which left about
760 emails that were assumed to have been received. Of these, three potential participants
called to inquire about the study and 15 replied by email to get more information on how
to participate in the study. One participant indicated that she did not want to participate in
the study. Twenty five participants agreed to have their medical records evaluated;
consent forms were obtained from all of these participants.
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The MDKT had the highest number of participants completing the questionnaire.
There were a total of 85 visits to the MDKT website. Fifty one (60%) participants
completed the MDKT; the results from one were not included in the final data set
because less than half of the questions were answered. From a total of 61 visits to the
demographic questionnaire, 47 (77.04 %) participants completed the questionnaire. For
the Block FFQ, there were 46 visits, 40 (86.95%) were completed. Thirty six participants
completed the Block questionnaire on the first visit. Six participants who had not fully
completed their questionnaires were contacted and reminded to complete the
questionnaire; 4 complied, for a total of 40 completed questionnaires.
Forty-seven participants completed the Demographic Questionnaire (Appendix
B); however, 1 subject had <50% completion and was excluded from analysis resulting in
46 satisfactorily completed questionnaires.
Demographic Questionnaire Results
The results from the demographic questionnaire are in Table 3.1. Demographic
information for CU4Health participants (1998 to 2009) is in Table 3.2. Most of the
participants in this study were female (80%) compared to 59.4% female in the
CU4Health program (785/1321). Both of these percentages were higher than the
percentage of female employees at CU (49.20%) in early 2008 (Table 3.3) (16).
The age group most highly represented was 50-59 years (46%) in this study and
in the CU4Health data (33.8%) (Table 3.4). Most study participants reported they were
Caucasian; (84%); the same percentage applied to the CU4Health and CU employee
population. Only 4% of participants reported that they smoked. Forty five percent of the
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participants reported they had BMI normal in the study, compared to 39.5% from
CU4Health data. Fifty-five percent of participants reported being either overweight
(33%) or obese (22%) (Table 3.1). BMI information in Table 3.1 was calculated from the
self reported height and weight values from the participants’ in this study. For
participants who allowed access to their CU4 Health clinical data, 52% had normal BMI,
26% were overweight and 22% were obese.
Sixty seven percent of study subjects were married and 22% divorced. CU4Health
participants who allowed access to their clinical data marital status were; 63.3% married,
23.3% divorced, 10% widowed and 3.3% single. The highest percentage of the
participants in the on-line study, 35%, had a graduate degree, and 33% had some college
education, while 43.3% of the CU4Health participants and 45.7% of all the university
employees had earned graduate degrees, and 25% of CU4Health participants and 20.4%
of university employees were college graduates. Of the study participants, 28% indicated
that they had a household income of ≥$80,000 and above while 36.2%, of the CU4Health
group were at this income level. For university employees, the most common income
level (41%) was $20,000 - $39, 999 while only 14.9% of employee households belonged
to the ≥$80, 000 income bracket. For the study group, 46% of the participants lived in a
2-person household, and there were no persons <18 yrs in 79% of the households, and no
persons > 65 in 94% of the households. An equal percentage of participants, 39%, lived
in Pickens and Oconee counties with 59% of the participants reporting that they lived in a
town or city of 10,000 to 15,000 residents.

83

Questionnaire Results
The mean (±SD) MDKT score, from the 50 participants, was 76.85±15.17
(P<0.001) with a mode of 85.71. Only 5 participants scored 100, with the five lowest
scores ≤57.14. Of the 16 questions asked, the HbA1c knowledge item had to lowest
percentage of correct answers (25%). Question 4, which assessed fat content in food, was
answered correctly by only 55 % of participants. Sixty percent of participants correctly
answered question 9 (treatment of low blood sugar), and 61% knew the effects of
infection on blood glucose (question 11). Sixty two percent of participants answered
question 5 correctly, which pertained to identifying calorie levels presented in food
labeling. Ninety two per cent of the participants answered a carbohydrate-related question
(question 12) correctly and 94% correctly answered the question on foot care. Ninety
eight percent of the participants were able to identify the correct answer in a
cardiovascular disease related question (question 13) (Appendix C).
The Block Food Frequency Questionnaire
Participants who completed the Block FFQ were Caucasian (87.5%) > African
American and Hispanic (7.5%, each) > Native Americans (2.5%), with 5% "other".
Females (77.5%) of average age 53.54± 8.50 and men (22.5%) of average age
48.44±10.46 participated. The mean for BMI was 27.09±5.85. In a scale of 2-7 (2completed HS; 7-Graduate degree), the mean educational attainment was a college
education. Only two participants reported smoking 6 and 15 cigarettes a day,
respectively. Approximately 37% reported drinking less alcohol than they used to, and
65% reported currently trying to lose weight.
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Health status was reported as excellent (20%), very good (47.5%), good (30%),
and fair (2.7%). Mean calories consumed were 1780±512.38 kcal. Average caloric
consumption was: protein 71.71g (36.58%); fat 72.85g (16.01%), and carbohydrates,
210.89g (47.69 %); sweets (12.60%) and alcohol (3.23%). Average fat sources were;
saturated fat 22.12±9.1g, monounsaturated fat 28.93±10.52g, and polyunsaturated fat
16.34±5.80g with 1.73±0.68mg Omega-3 fatty acids and 2.28±1.38mg trans fats. Daily
cholesterol intake was 70±97.95mg. The amount of dietary fiber consumed was
20.623±9.22g. The total amount of sugar consumed was 96.76±42.16g.
Participants reported that they consumed a relatively healthy diet with low total
calories for both the college educated and those without a college education. The data in
Table 3.5 indicates that there was no significant difference in caloric intake based on
level of education. Table 3.6 is composed of data of a comparison of My Pyramid
recommended diet and the results from this study. Participants in this study consumed, on
average, more vegetables (3.8± 2 cups) compared to the recommendations (2.5 cups).
They also consumed 1.5± 1 cups of fruits and juices compared to a recommended 2 cups.
Saturated fat intake was measured at a mean of 22± 9.10 g.
A Stepwise multiple linear regression was used to develop a model for the
diabetes knowledge score based on demographic and clinical variables was used. The
model formula is below:
MDKT score =72.3747*intercept-0.1214*total calories-0.0506*income
+30.8564*diabetes+ 17.1742*gender-0.2447*age-1.0365*bmi+3.69707*fat
calories+0.72651*carbohydrates colories-0.33111*saturated fat.

85

The results from the stepwise multiple linear regression model which did not
include the CU4Health clinical variables are shown in Table 3.9. There were 46
participants who were included in the full model. In a multivariate statistical (Table 10.9)
analysis it was shown that total calories (P = 0.0066), having diabetes (P = 0.0013),
gender (P = 0.0457), BMI (P = 0.0394), calories from fat (P = 0.0341), calories from
carbohydrates (P = 0.0018), were factors affecting diabetes knowledge score.
Insignificant factors in the model were income (P = 0.9801), age (P = 0.2863) and
education (P = 0.0793). Having diabetes was a significant factor (P = 0.0013), while
educational attainment was not (P = 0.0793). This meant that, for this group, people with
diabetes had better diabetes knowledge regardless of their educational attainment.
In a second model (Table 3.10) which included the clinical variables, hemoglobin
(P = 0.0004) and triglycerides (P = 0.0004) were important predictors of diabetes
knowledge. Other significant variable in the model were income (P = 0.0354), having
diabetes (P = 0.0021), education (P = 0.0250) and calories from carbohydrates (P =
0.0007). The formula for the second model is shown below:
MDKT score = -16.064*intercept+1.6281*income+14.4343*diabetes
+0.35468*bmi-2.1924*education+0.05366*carbohydrates calories
+7.04135*hemoglobin+0.03519*triglycerides-12.40535*diabetes2.
A comparison was made for the 25 participants who allowed access to their
clinical CU4Health values and some of the values they reported in this study (Table 3.7).
The longest time that any one participant had stayed in the program was 10 years and the
mean was 6.88± 3.04 (P <0.0001). The mean change in BMI was -0.58 (P<0.41) while
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the mean change in weight was -0.59 (P = 0.8680). The mean change in fasting glucose
was -4.01 (P = 0.3083).
Discussion
The CU4Health program provided an ideal group of candidates for this study. The
program participants are a self-selected group of individuals who have shown an interest
in seeking health information and education. The information given to them from the
blood profile tests and various scores on health and wellness provided yet another reason
for the individuals to improve their health. The nutritional score and counseling given to
the program participants provided some knowledge of healthy eating habits and
encouraged the individuals to seek more information in any areas that were problematic
for them.
In their health literacy study for diabetes patients, Powel and colleagues found
that there was a significant association between the level of literacy and the high score in
their program (P = 0.02) (25). In the present study there was no significant difference
detected among the education groups (P = 0.4921). Contrary to this study, Powell found
that there was a significant difference between high literacy patients and those with low
literacy and those with low literacy missed 13% to 18% of the questions. In this study
however, all the participants were of arguably high literacy level, making this difference
hard to measure. It could be said that the CU4Health program has produced positive
results because of the lack of significant difference between diabetes knowledge observed
among educational levels. CU4Health participants who did not have a college degree did
not score significantly different compared to those who had college degrees. This could
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mean that the information received through the CU4Health program may have reduced
the potential difference in diabetes knowledge score for CU4health participants. In a
large sample size study, Fitzegerald and colleges found that the Diabetes Knowledge Test
score increased with the level of education (21). This was also the case in this study;
however, the difference was not significant. The DKT means ±SD for different education
levels in this study were 74.1±15.8, 75.81±14.1 and 79.46±15.8 for those who do not
have a college degree, those with a college degree, and those with a graduate degree
respectively.
In 2001, Groth and colleagues reported that educational attainment was an
important factor in explaining the difference in healthy dietary habits between low and
higher education groups in Denmark (26). There was also a similar finding in a Canadian
study where high education participants were more likely to follow a meal plan (27) This
was not the case in our MDKQ results, as only 55% of the participants correctly
answered a question on types of food that were high on fat (question 4). It is rather
troubling that such a high percentage of people, who were mostly well educated, did not
understand variations in fat content among various food products. It is well known that
consuming a diet that is high in saturated fat and low in vegetables, fruits and whole
grains increases the chance of weight gain and the development of metabolic chronic
disorders. The reported food intake results from this study were encouraging, for example
participants reported a high intake of vegetables. However, the clinical data suggests that
this group needed to improve its diet. The average cholesterol levels were: total
cholesterol, 201±42.5 mg/dl; LDL cholesterol, 121.5±37.34 mg/dl; and HDL cholesterol,
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57±15.24 mg/dl; with mean triglycerides 138±162.98mg/dl. Desirable cholesterol
numbers are ≤200 mg/dl for total cholesterol, ≤100 mg/dl for LDL and ≥60 mg/dl for
HDL. Desirable triglycerides levels are ≤150 mg/dl. Subject lipid levels were less than
optimal and indicate that the CU4Health participants need to reduce their saturated fat
intake. This can be achieved by choosing their fats wisely and increasing their
consumption of whole grains and high fiber foods.
Some of the CU4Health program participants had already developed diabetes or
other chronic metabolic disorder as indicated in Table 3.1. With this in mind, this study
tested the diabetes and nutritional knowledge of the CU4Health program participants.
Participants with diabetes had better diabetes knowledge, regardless of educational
attainment.
The CU4Health program can best address health concerns of its participants if the
participants are familiar with diabetes education information. It has been shown that a
lifestyle that reduces the risk of developing diabetes is likely to reduce the risk of
developing other metabolic disorders, particularly stroke and CVD (most people with
diabetes die from stroke and CVD). Therefore, it was encouraging to find that there was
no significant difference between the college-educated group and those without a college
education in this study.
It was anticipated that an online study would increase participation of university
employees; however, this was not the case (participation rate was 7% of 760 emails sent).
It may be advisable to re-evaluate the recruitment method to increase participation. The
majority of the participants (~80%) were female; as a result there may be a need to
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conduct focus groups to gain more information on increasing male participation.
Conducting the study online did have the benefit of cost reduction and increased ease of
obtaining data.
Conclusions
In the CU4Health participants, no significant difference in diabetes knowledge
was observed between those with less than a college degree and those with a college
degree. No difference in reported amount of calories consumed/group was seen. The
factors, total calories (P = 0.0066), having diabetes (P = 0.0013), BMI (P = 0.0394), that
were found to be useful in predicting diabetes knowledge could be used when
constructing lifestyle interventions. The study findings indicated that the participants
consumed less than recommended servings of whole grain and dairy products. An
intervention that encourages the consumption of aforementioned products would be ideal
for the study participants. Participants had high diabetes knowledge but most did not
know much about the A1c test. An intervention that has an educational component
providing the latest information about diabetes and other chronic metabolic disorders
would increase their knowledge. The findings of this study enhance the understanding of
the eating habits and health conditions and diabetes knowledge of the CU4Health
participants. Information obtained from the current study can be used to design future
worksite interventions for diabetes, and other related chronic diseases, for CU4Health
participants or other interested Clemson University employees.
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Table 3.1: Study Population Demographic Characteristics
Variable

Values

Sex

Female
Male
30-39
40-49
50-59
60-69
70-79
Black/African-American
Caucasian
Hispanic/Latino
Native American
Yes
No
Normal (18.5-24.9)
Overweight (25-29.9)
Obese (30 or greater)
Married
Never married
Separated/Divorced
Widowed
Completed High School
Some College
Bachelor degree
In Graduate School
Graduate degree
Full Time
Part Time
Unemployed
$20,000-29,000
$30,000-39,000
$40,000-49,000
$50,000-59,000
$60,000-69,000
$70,000-79,000
$80,000 – 89,000
$90,000 – 99,000
≥$100 000
1
2
3

Age Group, yrs

Race

Smoke
BMI1, kg/m2

Marital Status

Education

Employment

Household Income

Individuals in
household
n (%)2
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Number

Percentage

36
9
3
13
21
8
1
3
40
3
2
2
44
20
15
10
31
1
10
4
1
15
13
1
16
43
2
1
2
5
5
9
4
6
2
6
4
9
21
9

80%
20%
6%
28%
46%
18%
2%
6%
84%
6%
4%
4%
96%
45%
33%
22%
67%
2%
22%
9%
2%
33%
28%
2%
35%
94%
4%
2%
5%
12%
12%
20%
9%
14%
5%
14%
9%
20%
46%
20%

4
6
14%
0
36
79%
1
4
9%
2
5
12%
> 65 yr
0
42
94%
1
3
6%
County Residence
Anderson
7
16%
Greenville
2
4%
Oconee
18
39%
Pickens
18
39%
Other
1
2%
Residence
Farm
1
2%
Population
> 150,000
2
4%
> 50,000 <150,000
3
7%
10,000 - 50,000
27
59%
< 10,000
13
28%
Reported Health
cardiovascular disease
1
2%
condition
diabetes
11
24%
high blood glucose levels
4
9%
high blood pressure
15
33%
high cholesterol values
14
30%
overweight or obese
12
26%
1
BMI values derived from self reported height and weight values.
2
Percentages based on the total number of participants who answered each question.
< 18 yrs
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Table 3.2 CU4Health Participant Demographic Characteristics, Fall 1998-Spring 2009
Variable

Values

Sex

Male
Female
< 20
20-29
30-39
40-49
50-59
60 and above
< 20,000
20,000-39,999
40,000-59,999
60,000-79,999
≥80,000
Some High School
High School Graduate
Some College
College Graduate
Graduate Degree
African American
Asian
Hispanic
Native American
Caucasian
Other
Colorectal Cancer
Breast Cancer
Diabetes
Cardiovascular Disease
High
Moderate
Low
Ideal
<25
25-29.9
≥30
<25
25-29.9
≥30
<25
25-29.9

Age Group

Family Income

Level of Education

Race

Family History of
Disease

Diabetes Risk Score

Male BMI, kg/m2
Female BMI, kg/m2
Group BMI, kg/m2
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Number

Percentage

536
785
2
90
249
376
446
158
29
155
169
155
288
22
98
192
246
426
98
44
22
24
1031
8
94
142
438
364
87
252
487
495
178
220
138
343
240
202
521
460

40.6%
59.4%
0.2%
6.8%
18.8%
28.5%
33.8%
12.0%
3.6%
19.5%
21.2%
19.5%
36.2%
2.2%
10.0%
19.5%
25.0%
43.3%
8%
3.6%
1.8%
2%
84%
0.7%
7.1%
10.7%
33.2%
27.6%
6.6%
19.1%
36.9%
37.5%
33.3%
41%
25.7%
43.7%
30.6%
25.7%
39.5%
34.8%

≥30

340

25.7%

Table 3.3 2008 Clemson University Employee Demographic Data
Variable

Values

Number

Sex

Percentage

Male
2494
50.80%
Female
2415
49.20%
Race
African American
10.21%
501
Asian
04.01%
197
Hispanic
01.22%
60
Native American
00.12%
6
Caucasian
84.21%
4134
Other
00.22%
11
Income
< 20,000
6.6%
264
(n = 3978)
20,000-39,999
41.0%
1631
40,000-59,999
22.3%
888
60,000-79,999
15.2%
605
≥80,000
14.9%
590
Education
Not Indicated
1.4%
55
(n = 3978)
Some High School
1.0%
34
High School Graduate
13.4%
531
Some College
18.1%
735
College Graduate
20.4%
806
Graduate Degree
45.7%
1817
th
*The percentages were rounded to the nearest 10 and total of 99.99
#Additional data provided by Dr. Ronald Chrestman, Office of Institutional Research,
Clemson University, Clemson, SC 29634
http://www.clemson.edu/oirweb1/fb/factbook/factbook.cgi?conf_file_name=zcFBE_Emp
loyeeFacBGR
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Table 3.4. Subject Demographic Information from the Current Study, Clemson
University and CU4health
Variable

Values

Current
Study

CU4Health

University

Male
Female

9 (20%)
36 (80%)

536 (40.6%)
785 (59.4%)

2494 (50.80%)
2415 (49.20%)

Race

African American
Asian
Hispanic
Native American
Caucasian
Other

3 (6%)
3 (6%)
2 (4%)
40 (84%)
-

98 (8%)
44 (3.6%)
22 (1.8%)
24 (2%)
1031 (84%)
8 (0.7%)

501 (10.21%)
197 (04.01%)
60 (01.22%)
6 (00.12%)
4134 (84.21%)
11 (00.22%)

Income

Under 20,000
20,000-39,999
40,000-59,999
60,000-79,999
80,000 and above

7 (16.2%)
14 (32.5%)
10 (23.2%)
12 (28.1%)

29 (3.6%)
155 (19.5%)
169 (21.2%)
155 (19.5%)
288 (36.2%)

264 (6.6%)
1631 (41.0%)
888 (22.3%)
605 (15.2%)
590 (14.9%)

Education

Not Indicated
Some HS
HS Graduate
Some College
College Graduate
Graduate Degree

1 (2.2%)
15 (32.6%)
14 (30.4%)
16 (34.8%)

22 (2.2%)
98 (10.0%)
192 (19.5%)
246 (25.0%)
426 (43.3%)

55 (1.4%)
34 (1.0%)
531 (13.4%)
735 (18.1%)
806 (20.4%)
1817 (45.7%)

Gender
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Table 3.5: Characteristics of CU4Health Participants by Educational Categories
No College
Means±SD
74.78±15.79
1882.8±595.10
2.06±0.92
53.57±.17
1.94±0.24
29.80±6.46
712.17±25
881.52±32

With College
Means±SD
78.56±15.24
1724.8±465
3.11±1.21
51.76±10.06
1.72±0.45
25.5±4.17
625.32±224
807.56±242

Item
N
N
p-value
MDKT Score
17
27
<0.611
Total Calories (kcal)
14
23
<0.378
1
Income
16
25
<0.003
Age (yrs)
14
25
<0.650
Gender* (M/F)
14
25
<0.045
BMI (kg/m2)
14
25
<0.431
Fat Calories (kcal)
14
23
<0.324
Carbohydrate
14
23
<0.440
Calories (kcal)
Saturated Fat Calories 14 224.64±83.60
23
185.22±79.1
<0.205
(kcal)
1.
Income categories: 1 = $20,000 – 29,000, 2 = 30,000 – 39,000, 3 = 40,000 – 49,000,
4 = 50,000– 59,000
*Gender: 1 = Male, 2 = Female

Table 3.6 Comparison of Foods Consumed by Subjects with the Recommended
MyPyramid Food Groups
Item
Vegetables
Fruits & fruit juices
Breads, cereals, rice,
pasta
Meat, fish, poultry,
beans, eggs
Milk, yogurt, cheese
Fats & oils, sweets,
sodas
Whole grains

Means Intake Per Day1,2
3.8± 2cups
1.5±1 cups
4.6±2.2 oz

Recommended3
2.5 cups
2 cups
10 oz

2.2±1.1 oz

5.5 oz

1.3±0.8 cups
3.0±1.1 tsp

3 cups
6 tsp

0.6± 0.8oz

6 oz

1.

n=25
Means ±SD
3.
Servings Recommended by MyPyramid, 2005
2.
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Table 3.7 Clinical Characteristics from the CU4Health Participants (n = 25) Grouped by College Education*1
No
degree
Mean

Hgb2
g/dL
12.8±1.0

Cholesterol3
mg/dL
218±36.6

LDL
mg/dL
131.7± 32

HDL
mg/dL
59.7±16.2

TAG4
Glucose
mg/dL
mg/dL
131.3± 87.3 92.4± 19.6

With
degree
Means

Hgb

Cholesterol

LDL

HDL

TAG

Glucose

BMI

14.1± 0.8

191± 43.7

115.0± 39

56.1±14.9

142.7± 197

99.5± 27.3

26.0± 5.5

*The characteristics above were not significant at the 0.05 levels of significance.
1
. Values are expressed as means ± standard deviation
2.
Hgb – Hemoglobin
3.
Cholesterol – Total Cholesterol
4.
TAG – Triglycerides
5.
BMI – Body Mass Index from CU4Health data
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BMI5
kg/m2
27.2± 7.7

Table 3.8. Correlated Valuables from the Full Research Data
Variables
Score and Age
Score and Being married
Score and Income
Education and Gender
Education and BMI
Education and Income
Total calories and BMI
Total calories and age
P-Value: 0.05 levels of significance
r- Is the correlation coefficient

P-Value
<0.0092
<0.0094
<0.0225
<0.0203
<0.0372
<0.0278
<0.0106
<0.0092
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R
-0.32
-0.31
0.37
-0.34
-0.30
0.33
0.40
-0.40

Table 3.9 MDKT Score Model for Data Set 1
Variable
Constant
Total calories
Income
Diabetes
Gender
Age
BMI
Education
Fat calories
Carbohydrates Calories
Saturated fat

Coefficient

P-value

72.3747
-0.1214
-0.0506
30.8564
17.1742
-0.2447
-1.0365
3.6970
1.0760
0.7265
-0.3311

<0.0082
<0.0066
<0.9801
<0.0013
<0.0457
<0.2863
<0.0394
<0.0793
<0.0341
<0.0018
<0.7124

Overall P-value 0.0102
Overall R2 0.8531

Table 3.10 MDKT Score Model for Data Set 2
Variable
Constant
Income
Diabetes
BMI
Education
Carbohydrates Calories
Hemoglobin
Triglycerides
Diabetes 2

Coefficient

P-value

-16.0640
1.6281
14.4343
0.35468
-2.1924
0.05366
7.04135
0.03519
-12.40535

<0.3361
<0.0354
<0.0021
<0.0819
<0.0250
<0.0007
<0.0004
<0.0004
<0.0135

Overall P-value 0.001
Overall R2 0.9492
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Appendix A
Study Website Page

Welcome to the

"Evaluation of Health, Diabetes Knowledge & Behaviors of CU4Health Participants
at Clemson University"

You are invited to participate in a research study
conducted by Vivian Haley-Zitlin, Ph.D., R.D., L.D.,
and Peter Mukwevho from the Department of Food
Science and Human Nutrition.
The purpose of this research is to assess health and
diabetes knowledge and behavior of employees at
Clemson University who have shown interest in their
health status by their participation in the CU4Health
program. The results from this study will be used to
design a comprehensive nutrition and health intervention for Clemson University
employees participating in CU4Health

In this website you will find the following:

•

You will be able to download and print a consent form

•

The Michigan Diabetes Knowledge Test

•

A Demographic Questionnaire

•

The Block Food Frequency Questionnaire

Please note that each link will open in a new window
Please review the IRB approved consent form

(pdf format)

Note: consent form must be read before opening the questionnaires
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•
•
•

Click here for the Diabetes Knowledge Test
Click here for the Demographic Questionnaire
Click here for the Food Frequency Questionnaire

Upon completion of consent forms participants will receive a packet of educational
materials which will include fact sheets and health related websites. Additional items
may include measuring cups, etc. Participants' names will be included in random
drawings for giveaways.
If you have any questions regarding this research, please contact me at the following
location:
Peter Mukwevho
Department of Food Science and Human Nutrition
A203C Poole Agricultural Center
Clemson University
(864) 656-5693
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Appendix B
Demographic Questionnaire

Demographic Questionnaire
Created: June 30 2009, 8:11 AM
Last Modified: June 30 2009, 8:11 AM
Design Theme: Basic Blue
Language: English
Button Options: Labels
Disable Browser “Back” Button: False
Page 1 - Question 1 - Open Ended - One Line

Name: please enter your name
Page 1 - Question 2 - Choice - Multiple Answers (Bullets)

What is your age group?
 18-19 years old
 20-29 years old
 30-39 years old
 40-49 years old
 50-59 years old
 60-69 years old
 70-79 years old
 80 years old and over
Page 1 - Question 3 - Choice - Multiple Answers (Bullets)

I would best describe myself as
 Female
 Male
Page 1 - Question 4 - Choice - Multiple Answers (Bullets)

I would best describe myself as
 Asian
 Black/African-American
 Caucasian
 Hispanic/Latino
 Native American
 Other, please specify
Page 1 - Question 5 - Open Ended - One Line

What is your height?
Page 1 - Question 6 - Open Ended - One Line

What is your height
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Page 1 - Question 7 - Choice - Multiple Answers (Bullets)

Do you smoke cigarettes?
 No
 Yes
 How many cigarettes do you smoke each day?

Page 1 - Question 8 - Choice - Multiple Answers (Bullets)

What is your marital status? (please check one)
 Married
 Never married
 Separated/Divorced
 Widowed
Page 1 - Question 9 - Choice - Multiple Answers (Bullets)

What is your highest education level completed? (please check one
 Completed college (4 year Bachelor degree)
 Completed Graduate or Professional School
 Completed High School/GED
 Currently attending college (4 year Bachelor degree)
 Currently attending Graduate School (Masters, Ph.D., M.D., etc.)
 Less than 12th grade
 Some College or Vocational School Training
Page 1 - Question 10 - Choice - Multiple Answers (Bullets)

Please check the one(s) which apply to you
 Employed full-time
 Employed part-time
 Not employed
Page 1 - Question 11 - Choice - Multiple Answers (Bullets)

What is the approximate level of your household income before taxes? (please check one)
 $10,000 – 19,000
 $100,000 and above
 $20,000 – 29,000
 $30,000 – 39,000
 $40,000 – 49,000
 $50,000 – 59,000
 $60,000 – 69,000
 $70,000 – 79,000
 $80,000 – 89,000
 $90,000 – 99,000
 Under $10 000
Page 1 - Question 12 - Open Ended - One Line

Number of people in household

107

Page 1 - Question 13 - Open Ended - One Line

Number of people in household under 18 years of
Page 1 - Question 14 - Open Ended - One Line

Number of people in household over 65 years of age
Page 1 - Question 15 - Choice - Multiple Answers (Bullets)

Place of residence
 City of 2000,000 – 400,000 people
 City over 400,000 (example: Greenville, SC)
 City with over 100,000 people
 City with over 150,000 people (example: Anderson, SC)
 Farm
 Suburb of city with over 50,000 people
 Town of less than 10,000 people or rural non-farm (example: Pendleton, SC; Easley, SC)
 Town or city with 10,000 to 50,000 people or their suburb (example: Clemson, SC;
Seneca, SC)
Page 1 - Question 16 - Choice - Multiple Answers (Bullets)
County residence








Anderson county
Greenville county
Oconee county
Pickens county
Spartanburg county
Other, please specify

Page 1 - Question 17 - Choice - Multiple Answers (Bullets)

Have you been diagnosed with any of the following by your health care provider? Please check
all that apply
 cardiovascular disease
 diabetes
 high blood glucose levels
 high blood pressure
 high cholesterol values
 overweight or obese
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Appendix C
Diabetes Knowledge Test

Michigan Diabetes Knowledge Test
Created: June 30 2009, 1:53 PM
Last Modified: June 30 2009, 1:53 PM
Design Theme: Basic Blue
Language: English
Button Options: Labels
Disable Browser “Back” Button: False

Diabetes Knowledge Test
Page 1 - Question 1 - Open Ended - One Line

What is your name? (Please write your first and last name
Page 1 - Question 2 - Choice - Multiple Answers (Bullets)

The diabetes diet is:
 a healthy diet for most people
 the way most American people eat
 too high in carbohydrate for most people
 too high in protein for most people
Page 1 - Question 3 - Choice - Multiple Answers (Bullets)

Which of the following is highest in carbohydrate?
 Baked chicken
 Baked potato
 Peanut butter
 Swiss cheese
Page 1 - Question 4 - Choice - Multiple Answers (Bullets)

Which of the following is highest in fat?
 Corn
 Honey
 Low fat milk
 Orange juice
Page 1 - Question 5 - Choice - Multiple Answers (Bullets)

Which of the following is a “free food”?
 Any dietetic food
 Any food that has less than 20 calories per serving
 Any food that says “sugar free” on the label
 Any unsweetened food
Page 1 - Question 6 - Choice - Multiple Answers (Bullets)

Glycosylated hemoglobin (hemoglobin A1) is a test that is a measure of your average blood
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glucose level for the past
 6 months
 6-10 weeks
 day
 week
Page 1 - Question 7 - Choice - Multiple Answers (Bullets)

Which is the best method for testing blood glucose?
 Blood testing
 Both are equally good
 Urine testing
Page 1 - Question 8 - Choice - Multiple Answers (Bullets)

What effect does unsweetened fruit juice have on blood glucose
 Has no effect
 Lowers it
 Raises it
Page 1 - Question 9 - Choice - Multiple Answers (Bullets)

Which should not be used to treat low blood glucose?
 1 cup diet soft drink
 1 cup skim milk
 1/2 cup orange juice
 3 hard candies
Page 1 - Question 10 - Choice - Multiple Answers (Bullets)

For a person in good control, what effect does exercise have on blood glucose?
 Has no effect
 Lowers it
 Raises it
Page 1 - Question 11 - Choice - Multiple Answers (Bullets)

Infection is likely to cause
 a decrease in blood glucose
 an increase in blood glucose
 no change in blood glucose
Page 1 - Question 12 - Choice - Multiple Answers (Bullets)

The best way to take care of your feet is to
 buy shoes a size larger than usual
 look at and wash them each day
 massage them with alcohol each day
 soak them for one hour each day
Page 1 - Question 13 - Choice - Multiple Answers (Bullets)

Eating foods lower in fat decreases your risk for
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eye disease
heart disease
kidney disease
nerve disease

Page 1 - Question 14 - Choice - Multiple Answers (Bullets)

Numbness and tingling may be symptoms of
 eye disease
 kidney disease
 liver disease
 nerve disease
Page 1 - Question 15 - Choice - Multiple Answers (Bullets)

Which of the following is usually not associated with diabetes
 kidney problems
 lung problems
 nerve problems
 vision problems
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Appendix D
Consent Form for Research Study
Consent Form for Participation in a Research Study
Clemson University
Evaluation of Health, Diabetes Knowledge and Behaviors of CU4Health
Participants at Clemson University.
Description of the research and your participation
A. You are invited to participate in a research study conducted by Dr. Vivian HaleyZitlin and Peter Mukwevho. The purpose of this research is to assess health and
diabetes knowledge and behavior of employees at Clemson University, who have
shown interest in their health status by their participation in the CU4Health program.
The results from this study will be used to design a comprehensive nutrition and
health intervention for Clemson University employees participating in CU4Health.
B. There are 2 options for participation:
1. You may choose to participate by completing the questionnaires and
granting us access to your CU4Health data.
Or
2. You may choose to participate by completing the questionnaires only.
Participation details are:
a) Assessment of your health and diabetes knowledge by completing a food
intake and diabetes knowledge questionnaire and demographic
information.
b) Granting access to your CU4Health program data which will include your
health and diet history along with your height, weight, BMI, blood
pressure, Blood Lipid Profile (cholesterol values and triglycerides), and
Blood Chemistry Profile including blood glucose (blood sugar) and
electrolytes as well as your demographic information.
The amount of time required to complete the online questionnaires will be approximately
35-60 minutes. Assessing your CU4Health program data will require no additional time
from you.
Risks and discomforts
No identifiable risk is expected to occur to participants from participating in this study; however,
there is always a risk of electronically transferred data being illegally intercepted. The benefits

to the participants will outweigh the risks, as the information obtained will be used to
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help develop a program for CU4Health participants to delay or prevent the development
of chronic disease.
Potential benefits
The information obtained from the questionnaires will be used to assess the health habits
of Clemson University employees who have participated in the CU4Health Wellness
Program. The information acquired may be used to recommend specific changes that will
be beneficial to the CU4Health participants. Information gained will used to design a
nutrition and health intervention for Clemson University employees. The information that
is obtained from this study may be used scientifically and may be helpful to others.
Protection of confidentiality
The records of your participation will be kept confidential. The investigator will maintain
your information, from your participation in this study and the information to be obtained
from the CU4Health data, in a locked cabinet and on a password-protected computer.
Your name will be used to link your questionnaire responses with your CU4Health
information. Your name and the data acquired from the questionnaires will be shared
with the Sullivan Center. Individuals will not be identified in publications arising from
this study.
In rare cases, a research study will be evaluated by an oversight agency, such as the
Clemson University Institutional Review Board or the federal Office for Human
Research Protections that would require that we share the information we collect from
you. If this happens, the information would only be used to determine if we conducted
this study properly and adequately protected your rights as a participant.
Voluntary participation
Your participation in this research study is voluntary. You may choose not to participate
and you may withdraw your consent to participate at any time. You will not be penalized
in any way should you decide not to participate or to withdraw from this study. It is
preferable to the research team if you participate fully in the study.
Contact information
If you have any questions or concerns about this study or if any problems arise, please
contact Vivian Haley-Zitlin, Ph.D., R.D., L.D. at Clemson University phone number,
864-656-7716. You are encouraged to ask questions you may have during the course of
this study. If you have any questions or concerns about your rights as a research
participant, please contact the Clemson University Office of Research Compliance at
864.656.6460.
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C. Please check the box below to indicate your preferred level of participation.
If you would like to grant us access to your CU4Health data please sign and send in /
drop off the signed consent forms back to us.
I wish to participate fully (questionnaires + CU4Health)
I wish to complete the questionnaires only
If you have any questions or concerns please contact Peter or Vivian prior to
submitting your consent form or check the boxes below
Please contact me for informed consent questions
Please do not contact me

Consent
I have read this consent form and have been given the opportunity to ask questions.
I give my consent to participate in this study.
Name (please print): __________________________________
Participant’s signature: ________________________________ Date: ______________
Please submit your consent form by interoffice mail by (date) to:
Dr. Vivian Haley-Zitlin
Food Science and Human Nutrition Department
211 Poole Agricultural Center
Clemson University
Clemson, SC 29634-0316
Or
Contact Peter Mukwevho at (864) 656-5693 for a consent form delivery or pick-up.
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